Modelling Cellular Permeability via Carrier Mediated Transport by Sarupinda, Tendai Ishmael
  
 
MODELLING CELLULAR PERMEABILITY VIA  
CARRIER MEDIATED TRANSPORT 
 
 
 
By 
Tendai Ishmael Sarupinda  
November 2015 
 
 
 
 
 
 
 
 
 
A THESIS SUBMITTED TO THE UNIVERSITY OF HERTFORDSHIRE  
IN PARTIAL FULFILLMENT OF THE REQUIREMENTS FOR THE DEGREE OF 
MASTER OF SCIENCE BY RESEARCH  
1 
 
Abstract 
The relative importance of passive diffusion and carrier mediated transport 
processes to membrane permeability of drugs is a subject of current debate. Passive 
diffusion and carrier mediated transport are the two main methods by which drugs 
permeate the cell membrane. The permeability of molecules through membranes 
can have an impact on their absorption, distribution, metabolism and excretion 
(ADME) properties. It is therefore important to be able to predict the extent to which 
novel molecules can permeate the cell membrane. In vitro models of human 
intestinal absorption can be used to predict the likelihood of molecules permeating 
the human intestinal epithelium. Quantitative structure activity relationships (QSAR) 
techniques explain the relationship between molecular structure and cellular 
permeability. Current QSAR methods make use of physicochemical and structural 
property descriptors. These descriptors are able to predict the membrane 
permeability of molecules via passive diffusion rather than via membrane 
transporters. The aim of this study was to develop novel descriptors of carrier 
mediated transport that can be used in the development of QSAR models of 
permeability. The concept of metabolite likeness was investigated for its utility as a 
measure of the likelihood of molecules undergoing carrier mediated transport. This 
investigation found that approved drugs are generally more similar to human 
endogenous metabolites than molecules found in commercial databases. The use of 
a protein target prediction tool, PIDGIN, was also investigated. This study found that 
a relatively small number of membrane transporters that are expressed in caco-2 
cells have models available in PIDGIN. New QSAR models of membrane permeability 
were developed using physicochemical and structural property descriptors and in 
combination with the novel descriptors of carrier mediated transport. Novel models 
for predicting drug efflux ratio were developed and perform well in validation tests. 
Comparisons of predictive performance between QSAR models generated from 
physicochemical property descriptors alone and in combination with ‘carrier-
mediated transport descriptors’ were carried out. The general observation was that 
the novel descriptors of carrier mediated transport pursued did not significantly 
improve the predictive performance of models. However, some substructures from 
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the MACCS keys list, which are relevant to protein binding, were found to be 
important determinants of caco-2 permeability of molecules and could potentially be 
used to identify molecules that may undergo active transport. The performance of 
logistic regression classification models of efflux ratio was 88%. Not many studies 
have developed QSAR models of efflux ratio. This is a relatively novel approach 
which could be useful in identifying, and thus help to avoid, potential substrates of 
efflux transporters in drug discovery. 
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1. INTRODUCTION 
 
Not only do successful drugs have to demonstrate potency against their intended 
protein targets, but they must also possess good absorption, distribution, 
metabolism and excretion (ADME) properties. As of 2004, 50% of drug candidates 
failed due to poor ADME and toxicity properties in drug development (Hou, Zhang, 
Xia, Qiao, & Xu, 2004). Due to these high attrition rates, ADME properties are being 
considered in the early stages of drug discovery and development, resulting in 
significant reduction of ADME related attrition. However, the cost associated with 
experimental evaluation (in-vitro or in-vivo) of ADME properties is great. Therefore, 
cheaper alternatives such as computational (in-silico) techniques for predicting 
ADME properties prior to synthesis are considered (Cheng, Li, et al., 2012). 
Drug bioavailability is dependent on the extent to which the drug is absorbed into 
cells. Absorption is therefore an important property, the prediction of which is of 
immense value in drug discovery. While many factors influence the extent of 
absorption and therefore bioavailability, membrane permeability is arguably a very 
important factor. This is evidenced by the number of studies aiming to predict 
membrane permeability through in-silico, in vitro and in-vivo methods (Deli, 
Ábrahám, Kataoka, & Niwa, 2005; Dolghih & Jacobson, 2013a; T. Hou, Wang, Zhang, 
Wang, & Xu, 2006; Sevin et al., 2013; Stenberg, Norinder, Luthman, & Artursson, 
2001).   
To be effective, most drugs must cross cell membranes to reach, and interact with, 
their intracellular biological targets. The structure of cell membranes is such that 
they are effective regulators of passage of substances into and out of the cell. 
Depending on the chemical properties of the substance, passage into the cell can 
occur by one (or more) of four methods: passive transcellular diffusion, carrier 
mediated transport, transcytosis and paracellular transport (through intercellular 
gaps between cells). Passive diffusion generally occurs when sufficiently lipophilic 
molecules interact with phospholipids in the membrane (Sugano et al., 2010). There 
is no direct evidence suggesting that passive diffusion is the main method of drug 
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permeation, however, it is often the case in drug discovery projects that molecules 
are designed to be more lipophilic in the hope of making the compound more 
permeable via passive diffusion. This approach is understandable given the difficulty 
of designing molecules that can interact with specific membrane transporters as well 
as their protein targets. To design such a drug, one would require the drug to 
possess chemical features necessary for binding to the membrane transporter as 
well as to the intended target protein. Lipinski’s rule of 5 is a widely known rule used 
in drug discovery for assessing whether a molecule is likely to be orally active in 
humans (Lipinski, Lombardo, Dominy, & Feeney, 2012). However, the rule does not 
apply to substrates of membrane transporters and is therefore not applicable to all 
molecules.  
The increase in computational power has accompanied an increase in in-silico 
methods in drug discovery (Ekins, Mestres, & Testa, 2007). A wide range of in-silico 
methods have been developed, ranging from complex mathematical simulations of 
biological systems using molecular and quantum mechanical (QM) methods (van der 
Kamp & Mulholland, 2013) to statistical methods of predicting the behaviour of 
molecules in physiological environments. Quantitative structure-activity 
relationships (QSAR) modelling is an example of a statistical method often applied to 
predict bioactivity or other properties of interest (e.g. permeability) of molecules as 
a function of numerical molecular descriptors (Dehmer, Varmuza, & Bonchev, 2012). 
Some advantages of QSAR modelling include the speed by which models can be 
generated and the fact that molecular descriptors required for generating the 
models can be calculated from the chemical structure alone (Yee & Wei, 2012). 
One limitation of current QSAR methods of predicting membrane permeability is 
that they make use of physicochemical property descriptors which are better at 
predicting the permeability of molecules via passive diffusion than carrier-mediated 
transport. Because cell membranes contain several membrane transporters, it is 
likely that the permeability of drug molecules is greatly influenced by carrier 
mediated transport. Both membrane transporters and drugs are promiscuous in 
their nature; a drug can bind to several transporters and transporters can recognise 
several drugs which may or may not be structurally similar (Kell, Dobson, Bilsland, & 
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Oliver, 2013). This makes it a difficult task to develop predictive models for 
identifying potential substrates of membrane transporters. Unsurprisingly, not many 
studies of QSAR incorporate descriptors of carrier mediated transporters. The aim of 
this study is to assess the utility of the recently proposed concept of metabolite-
likeness and predictions of affinity to membrane transporters as novel descriptors of 
carrier mediated transport for use in the development of predictive QSAR models of 
membrane permeability. 
 
1. 1 Structure of the Cell Membrane  
To address the permeability of molecules through cell membranes, it is important to 
consider the relationship between the structure of cell membranes and how this 
relates to its function in terms of passage of substances.  
The cell membrane is made up of a phospholipid bilayer in which membrane 
proteins and carbohydrates etc. can be found embedded (Goñi, 2014). Cell 
membranes are often referred to as biological barriers which regulate the entry and 
exit of substances into and out of the cell respectively, maintaining an environment 
under which the cell exhibits optimal functioning (Sugano et al., 2010). The 
phospholipids that make up the bilayer are made up of polar phosphate groups more 
commonly known as ‘hydrophilic heads’ facing the aqueous media, and fatty acid 
chains that make up the hydrophobic tails. A common representation of the cell 
membrane is the fluid mosaic model (Figure 1) (Nicolson, 2014).  
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Figure 1: Illustration of the fluid mosaic model (Nicolson, 2014) 
Intracellular organelles, such as mitochondria and nuclei, may also have membranes 
that regulate the passage of substances (Stryer & Gumport, 1995). Consequently, 
drugs that target proteins inside these organelles require properties that enable 
them to cross both the cellular membrane and the organelle membrane. Cell 
membranes also contain receptors on the extracellular side to which specific 
external stimuli can bind and trigger a reaction cascade or signal transduction within 
that particular cell (Rothfield, 1971). They also contain a wide range of membrane 
transport proteins that facilitate the movement of molecules across the membrane 
(Goñi, 2014). Membrane transporters that can be found in the membrane include 
ion channels, and uptake and efflux transporters. Uptake and efflux transporters are 
involved in carrier-mediated transport of molecules into and out of the cells 
respectively. Energy, in the form of ATP, is required for uptake and efflux pumps. Ion 
channels facilitate passive diffusion of ions, such as sodium and potassium ions, that 
cannot permeate through the lipid bilayer due to their charge.  
It is generally thought that many drug molecules are transported across biological 
membranes via passive transcellular diffusion (through the membrane lipids) at a 
rate related to their lipophilicity. However, the chemical features considered 
important for molecules to interact with membrane lipids are also important for 
interaction with membrane transporters. A recent hypothesis proposes that carrier 
mediated transport accounts for the majority of membrane drug transport in 
biological systems (Dobson & Kell, 2008a; Kell, Dobson, & Oliver, 2011).  
The structure of the membrane is therefore closely related to its function. There are 
several methods by which molecules can enter the cell. In order to address cellular 
permeability of molecules, one must take into account all the possible methods. 
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1. 2 Methods of membrane transport 
 
 
Figure 2: Methods of transport across cell membranes 
1.2.1 Passive diffusion of drugs through cell membranes  
Movement of molecules across the membrane through lipids is referred to as 
transcellular passive diffusion (Figure 2). No energy is required for this process and 
molecules with a higher degree of lipophilicity tend to cross the membrane more 
readily along their concentration gradient (Stryer & Gumport, 1995). It is widely 
believed that passive diffusion across cell membranes is the predominant transport 
method of most drugs (Kerns & Di, 2008). The process of passive diffusion is 
described in detail by Kerns and Di (Kerns & Di, 2008). The process begins with the 
shedding of water molecules surrounding the drug molecule where hydrogen bonds 
are broken, allowing the molecule to pass through the polar regions of the 
phospholipids. Molecules then move to the tightly packed lipid chains surrounding 
the glycerol backbone and then move towards the more disordered aliphatic chains 
in the middle of the bilayer. Small molecules pass through the tightly packed chains 
more readily whilst highly lipophilic molecules are more permeable in the non-polar 
centre of the membrane. Molecules then pass through the second layer of the 
membrane and are rehydrated by water molecules, forming hydrogen bonds.  
1.2.2 Carrier-mediated transport of drug molecules 
Movement of drug molecules across cell membranes can be mediated by membrane 
transporters (Figure 2). These membrane transporters may be responsible for uptake 
of molecules into the cell (uptake transporters) or efflux out of the cell (efflux 
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transporters). Examples of uptake transporters include the organic uptake transport 
proteins (OATPs) which consist of 11 members (Roth, Obaidat, & Hagenbuch, 2012) 
and the monocarboxylate transporters (MCTs) responsible for transport of molecules 
that contain a single carboxylate group (Halestrap & Wilson, 2012). Examples of 
efflux transporters include the widely studied Permeability glycoprotein (P-gp) and 
the breast cancer resistance protein (BCRP). The degree to which membrane 
transporters contribute to the permeation depends on the structure of the molecule 
and the cell membrane in question (Sugano et al., 2010). This process is often 
referred to as active transport because energy, in the form of adenosine 
triphosphate (ATP), is required. Membrane transporters can therefore affect the 
ADME properties of drug molecules and substrate binding to membrane 
transporters should be considered in membrane permeability studies.  
 
1.3 Relative importance of passive diffusion and carrier mediated 
transport 
The relative importance of passive diffusion and active transport to the 
pharmacokinetic profile of drug molecules is a topic of current debate (Sugano et al., 
2010). The general perception is that carrier-mediated transport is rare compared 
with passive diffusion. The most likely reason for this perception is because 
molecules that are more lipophilic tend to exhibit higher permeability compared 
with less lipophilic molecules (Di et al., 2012; Lipinski et al., 2012; Sugano et al., 
2010). 
However, a review of the literature suggests no evidence supporting this perception 
exists. Recently, Kell et al. (Dobson & Kell, 2008a; Kell, 2015a; Kell et al., 2011) 
proposed that carrier-mediated transport is in fact the main method of transport 
and passive diffusion is negligible, a proposal that has, unsurprisingly, received much 
criticism. Di et al (Di et al., 2012; Kerns & Di, 2008) and Sugano et al. (Sugano et al., 
2010), among others, propose the co-existence of passive and carrier mediated 
transport in drug permeation.  
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The notion of passive diffusion being the main method of permeation has been 
challenged. Dobson and Kell (2008) have proposed that carrier-mediated transport is 
the ‘rule rather than the exception’ (Dobson & Kell, 2008b). If that is the case, 
successful in-silico modelling of carrier-mediated transport processes should 
improve the accuracy of in-silico permeability predictions. Models of permeability 
are currently based on physicochemical descriptors that are more capable of 
predicting the likelihood of a molecule undergoing passive diffusion than carrier-
mediated transport. The proposal that drug cell permeation is carrier-mediated only 
has triggered a debate on the matter (Di et al., 2012; Dobson & Kell, 2008b; Kell, 
2015b; Kell et al., 2011).  
According to Kell et al., there is increasing evidence pointing at the idea that drugs 
enter cells by ‘hitchhiking on carriers’ that normally transport nutrients and 
endogenous metabolites across the membrane (Kell et al., 2011). One of the 
arguments raised in support of a carrier-mediated only hypothesis is that 
permeation through lipid membranes is negligible because the protein-lipid mass 
ratio in cell membranes ranges between 1:1 and 3:1. Should this be the case, one 
would expect carrier-mediated transport to be more prevalent than passive 
diffusion. While this ratio may seem to support the notion of a carrier-mediated only 
process, it is worth analysing the abundance of proteins that are membrane 
transporters rather than just proteins because the cell membrane is known to 
contain various types of proteins, many of which are surface receptors. If the 
protein-lipid ratios mentioned above are in fact correct, it is reasonable to conclude 
that artificial membranes, such as the parallel artificial membrane permeability assay 
(PAMPA) (Bermejo et al., 2004), do not resemble biological membranes because 
they are made up entirely of lipids. The suggestion is that these assays are irrelevant 
and therefore cannot be used as an indicator of permeability in biological 
membranes. Indeed the above study mentions cases where molecules have 100-fold 
greater permeability in cell systems than in artificial membranes.  The most likely 
reason for this is the influence of carrier-mediated transport. However, other reports 
have shown that some compounds are more permeable in artificial membranes than 
in cell-based systems. A recent report claims that permeability of a small set of 
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carboxylic acids obeys Overton’s rule which states that more lipophilic molecules 
cross the phospholipid bilayer quicker (Li, Hu, & Malmstadt, 2011). For that set of 
molecules, one would expect passive diffusion to be the predominant transport 
mechanism.  
Some molecules tested in different cell-lines (e.g. caco-2 and MDCK) show different 
permeability values (Di et al., 2012). The most likely reason for these differences is 
the difference in morphology of the relevant cell lines. If passive diffusion is the main 
method of permeation for all drug molecules, one may expect fairly equal 
permeability values between cell lines. However, other factors may influence 
differences in permeability between cell lines e.g. difference in thickness and the 
degree of heterogeneity of the membranes (Sugano et al., 2010). It is the major 
differences in permeability that can therefore be attributed to the difference in 
membrane transporters expressed in different cell lines. For example if a molecule 
has high permeability in a caco-2 cell line but is not permeable in a MDCK cell, one 
would expect carrier-mediated transport to be the main factor and passive diffusion 
to be negligible for that particular molecule.  
When passive diffusion is dominant, transport rates are expected to increase linearly 
with concentration and rates are expected to be equal in both directions (Matsson et 
al., 2015). However, concentration dependence of transport rate does not exclude 
active transport. At high concentrations, membrane transporters become saturated 
and transport rate reaches a ‘steady state’ and becomes independent of drug 
concentration. At low drug concentration, saturation of membrane transporters may 
not be observed and one can expect such linear relationships between concentration 
and transport rate.  
Collectively, the evidence suggests that both passive diffusion and carrier-mediated 
transport can contribute to the permeability of molecules and the relative 
importance of each process depends on the molecule and the cell membrane in 
question. 
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1.3.1 Physicochemical properties affecting permeability 
There are many factors known to influence the permeability of molecules  including 
hydrogen bonding capability, lipophilicity, molecular size and ionization state (Hou et 
al., 2006). 
The octanol-water partition coefficient (Kow) is widely used in drug discovery to 
measure the lipophilicity (or hydrophobicity) of a molecule (Waring, 2010). 
Lipophilicity is an important descriptor that measures the extent to which a molecule 
partitions in aqueous or hydrophobic environments such as the phospholipid section 
of cell membranes. Due to its widespread use, lipophilicity is considered one of the 
most successful physicochemical property descriptors in medicinal chemistry (Testa, 
Crivori, Reist, & Carrupt, 2000). Many studies have found correlations between 
lipophilicity and bioactivity or other behaviour of interest such as cellular 
permeability (Kah & Brown, 2008; Waring, 2010). The partition coefficient, logP, 
quantifies the partitioning of neutral molecules between octanol and water. The 
disadvantage of logP is that it is only applicable to neutral molecules. Many 
molecules are ionisable and the logP value of ionisable compounds is pH dependent. 
The distribution ratio, (logD), is used to measure the lipophilicity of both neutral and 
ionisable compounds and is therefore more useful than logP in the drug 
development process (Kah & Brown, 2008). Molecules that are highly lipophilic are 
generally more permeable than molecules that are less lipophilic (Arnott & Planey, 
2012). However, molecules that are too lipophilic have low solubility therefore the 
relationship between lipophilicity and permeability is non-linear. This is one of the 
reasons why passive diffusion is regarded the main process of drug cellular 
permeation. The basis of this reason is that the higher the lipophilicity, the more 
likely it is that the molecule will interact with the phospholipid regions of the cell 
membrane (Arnott & Planey, 2012; Kah & Brown, 2008; Waring, 2010). 
However, high lipophilicity does not render a molecule unable to interact with 
membrane transporters. Chemical features that contribute to high lipophilicity are 
also relevant to protein binding e.g. a large number of methyl groups increase 
lipophilicity but these are also important for hydrophobic interactions with proteins 
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(Kell & Oliver, 2014). This is one of the points raised by Kell et al. who suggested drug 
transport is “essentially carrier mediated only” (Kell et al., 2011). 
For orally administered drugs to permeate the intestinal membrane, they must be 
soluble. Solubility is a measure of amount or concentration of the drug that can be 
dissolved in a particular medium. Poor solubility values often result in poor ADME 
properties. There is usually an inverse relationship between solubility and 
lipophilicity therefore a trade-off between the two properties is often required when 
developing drugs with optimal ADME properties. 
The majority of molecules can exist in both ionized and unionised states because 
they are either weak bases or acids. The amount of ionized and unionized drug 
depends on the pH of the solvent. The unionized form of a drug is widely reported to 
permeate the cell membrane via passive diffusion. It was also perceived that the 
unionized form of the drug was impermeable but studies suggest this is not always 
the case (Kah & Brown, 2008). It is likely that the unionized form permeates via 
passive diffusion while the ionized form permeates via carrier-mediated transport. 
The acid dissociation constant, pKa, is used as a measure of the extent of ionization 
at a given pH value and is dependent on the strength of acidic and basic groups in 
the molecule (Manallack, 2011). 
The significance of molecular size in permeability is demonstrated by its inclusion in 
the Lipinski’s rule of 5 which states that, among other rules, a molecule is unlikely to 
be absorbed if it has molecular weight greater than 500 Daltons (Lipinski et al., 2012; 
Newby, 2014). The increase in size of molecules is accompanied with poor 
permeability in particular via passive diffusion. There are however exceptions for 
molecules that undergo carrier-mediated transport; molecules of large size have 
been reported to permeate via carrier-mediated transport (H. Sun & Pang, 2007). 
 
1.4 In-vitro models of cell permeability 
The advancement in combinatorial chemistry and high throughput techniques has 
caused an increase in numbers of molecules in compound libraries that require 
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experimental testing (Irvine et al., 1999). ADME properties of drug molecules 
influence the amount of drug molecules that reach circulation and consequently 
their targets. It is therefore essential to have models for predicting the likelihood of 
compounds being permeable early in the drug discovery pipeline. Animal models can 
be used for such tests; however, the cost of animal model studies makes this 
approach unattractive for early drug discovery purposes. In vitro methods are a 
cheaper and faster approach and consequently, a wide range of in vitro systems 
have been developed to predict human intestinal absorption. In vitro models range 
from simple methods that determine the partitioning of a molecule in different 
solvents to more complex cell culture and whole tissue methods (Deli et al., 2005). 
1.4.1 Colon adenocarcinoma (Caco-2) cells 
The most commonly used in vitro method for predicting absorption is the caco-2 cell 
(Calcagno, Ludwig, Fostel, Gottesman, & Ambudkar, 2006; Guangli & Yiyu, 2006; 
Pham-The et al., 2011). While derived from the human colon, caco-2 cells 
differentiate to resemble the intestinal epithelium when cultured under specific 
conditions. Because they retain many morphological and functional properties of the 
intestinal epithelium, they are considered the gold standard for human intestinal 
permeability studies. Caco-2 permeability is widely reported to correlate well with 
human intestinal absorption (Kerns & Di, 2008). The widely acknowledged 
importance of caco-2 cells for permeability studies has caused an upsurge in 
computational studies aiming to predict the caco-2 permeability of compounds.  
1.4.2 Parallel artificial membrane permeability assay (PAMPA)  
PAMPA is a method used to determine the permeability of compounds through an 
artificial membrane made up of lipids (Bermejo et al., 2004). The main use of the 
PAMPA assay is to assess the likelihood and the extent to which molecules undergo 
passive diffusion. One obvious disadvantage of PAMPA is that only passive diffusion 
can be predicted. While passive diffusion is regarded to be the main method by 
which drugs enter cells, the main outcome of the recent debate on the relative 
importance of passive diffusion and active transport was the agreement of a 
coexistence of both processes. This presents another obvious limitation of PAMPA: a 
lack of carrier-mediated transport processes. The results obtained from such cell 
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lines have been questioned. If carrier-mediated transport is indeed more prevalent 
over passive diffusion, permeability through PAMPA may be irrelevant. However, 
many have observed good correlation between PAMPA permeability and in-vivo 
permeability.  
1.4.3 Mardin-Darby Canine Kidney (MDCK) 
The (MDCK) epithelial cells can also be used in permeability screening of chemical 
compounds (Irvine et al., 1999). While the cell line is derived from canine (dog) 
kidney, reports suggest that MDCK permeability show good correlation with both 
Caco-2 and human intestinal permeability. Because of the time required to culture 
Caco-2 cells, the MDCK cell line is sometimes used in early stage drug discovery to 
predict membrane permeability (Volpe, 2008). The obvious limitations lie in the 
differences in morphology between canine kidney and human intestinal epithelial 
cells. Another limitation of MDCK cell lines is the variation in observed permeability 
values of the same molecules between different laboratories (Volpe, 2008). This 
variation is most likely due to the different culture conditions applied in different 
laboratories which may cause differences in the morphology of the cell lines.  
 
1.5 The concept of molecular similarity  
The concept of molecular similarity has widespread use in drug discovery and 
medicinal chemistry. The similar property principle states that structurally similar 
molecules are likely to share similar properties (Eckert & Bajorath, 2007; Mestres & 
Maggiora, 2006). This principle forms the basis of the concept of molecular 
similarity.  
The concept of bioisosterism is a typical example of an application of molecular 
similarity (Patani & LaVoie, 1996). Bioisosteric groups are functional groups that can 
be interchanged within a molecular structure and still maintain activity. This 
approach has been employed, in particular, to replace toxic groups with safer 
functional groups (Patani & LaVoie, 1996).  
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The structural similarity of ligands has been applied as a method of relating protein 
function. In this approach, ligands of each protein are collected and based on their 
overall similarity proteins can be considered similar or dissimilar in terms of function. 
A study by Keiser et al. (Keiser et al., 2007) illustrates how protein functioning can be 
predicted based on the similarity of their ligands. The aim was to group and relate 
proteins based on the similarities of their ligands and to create a similarity map of 
enzymes and receptors. Depending on the availability of data, it may be possible for 
a similar approach to be taken to identify transporter substrates and to also relate 
membrane transporters with respect to similarity of their substrates.  
Other methods based on the concept of molecular similarity include the 
development of target prediction tools. Known active molecules against a particular 
target are collected and based on the similarity coefficients, new molecules can be 
predicted as substrates or non-substrates of the relevant target. An example is the 
PIDGIN tool that makes use of activity and inactivity information for a particular 
target (Mervin et al., 2015). The tool contains predictive models for 1080 protein 
targets for which novel molecules can be predicted as substrates or non-substrates 
depending on structural similarity to active or inactive molecules for the relevant 
target. 
There are however some limitations to the concept of molecular similarity. One 
limitation is that not all structurally similar molecules have similar biological activity 
profiles as single point changes in molecular structure may cause drastic changes in 
biological activity (Guha & Van Drie, 2008; Maggiora, 2006). Pairs of molecules with 
small differences in structure but significant differences in activity are often referred 
to as activity cliffs. While activity cliffs demonstrate that molecular similarity does 
not always correspond with similar biological activity, studies of single point changes 
can identify important sites for biological activity (Stumpfe, Hu, Dimova, & Bajorath, 
2014). Another limitation is that molecular similarity is highly context dependent 
(Mestres & Maggiora, 2006). For example, two molecules may have similar 
molecular weights but their lipophilicity may differ drastically. 
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1.5.1 Molecular Fingerprints  
The process of comparing molecules requires methods of representing the molecular 
structure and metrics for assessing structural similarity. A wide range of descriptors 
are available for use in calculating molecular similarity. Descriptors are designed to 
represent molecular composition in a given descriptor space. The first stage in 
structural similarity comparisons is the generation of molecular descriptors. Once 
descriptors are generated, a measure of similarity is required. An example is the 
widely used Tanimoto coefficient which calculates similarity based on binary 
representations of molecules (Cereto-Massagué et al., 2015). Given two binary 
representations pertaining to two molecules, A and B, the Tanimoto coefficient 
calculates structural similarity as a function of the overlap of binary attributes set to 
‘1’, N, as illustrated in the equation below.  
𝑇(𝑎, 𝑏) =
𝑁𝐴&𝐵
𝑁𝐴+ 𝑁𝐵− 𝑁𝐴&𝐵
  
The Tanimoto coefficient takes the range 0-1, 0 meaning no structural similarity and 
1 meaning very structurally similar. It is important to note that a Tanimoto value of 1 
does not necessarily mean that the two molecules being compared are the same. 
Enantiomeric molecules, such as Thalidomide, are an example where two molecules 
will have a Tanimoto coefficient of 1 although the two enantiomers differ chemically. 
2D fingerprints are some of the most commonly used descriptors of molecular 
structure because they are fast to compute and are information-rich in terms of 
differentiating molecules according to bioactivity. Molecular fingerprints are binary 
representations of molecular structure which encode the presence or absence of 
chemical features in a molecule. 2D fingerprints can be divided into two main 
groups: predefined fragment dictionary based and those based on hashing methods 
(Leach & Gillet, 2007). In dictionary-based fingerprints, often referred to as structural 
keys, each bit represents a specific substructure from the predefined library. A 
common example is the MACCS keys fingerprint which contains 166 predefined 
substructures (Durant, Leland, Henry, & Nourse, 2002). While such fingerprints are 
widely used in substructure searches, one of their disadvantages is that they may not 
encode novel substructures. 
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Hashed fingerprints on the other hand are not based on a predefined fragment 
library which means that any substructure in any given molecule may be encoded 
(Leach & Gillet, 2007). However, these fingerprints are difficult to interpret because 
it is not possible to identify the specific substructure encoded by a specific bit in a 
binary string. Their main use is for calculating molecular similarity rather than 
performing substructure searching (Rogers & Hahn, 2010a). Examples include 
extended connectivity fingerprints (Rogers & Hahn, 2010b) which encode the 
neighbourhood of each atom within the molecule, and Daylight fingerprints (Butina, 
1999) which encode atom pair information. 
1.5.2 Cluster analysis 
Molecular clustering is the process by which groups of molecules are put into 
clusters such that structurally similar molecules are found in the same cluster while 
dissimilar molecules are found in different clusters (Leach & Gillet, 2007). The first 
step in cluster analysis involves the generation of molecular descriptors. The second 
step involves using a metric for calculating the similarity or dissimilarity between all 
molecules. A clustering algorithm is then used in the third step to put molecules into 
clusters. Because ‘distance’ is used, this method is sometimes referred to as a 
distance-based measure approach of grouping molecules. When binary descriptors 
(fingerprints) are used, similarity coefficients (S) can be calculated and the distance is 
calculated as 1-S (Leach, 2001; Leach & Gillet, 2007). 
Cluster analysis is a common cheminformatics technique that is usually applied to 
diversity selection (Khanna & Ranganathan, 2011). The similar property principle, as 
stated previously, is one reason why one would want a diverse set of molecules in a 
dataset of interest. If structural similarity corresponds to similar biological activity, a 
diverse set of molecules allows for wider coverage of activity space. In some cases 
cluster analysis is used to reduce the number of compounds of a certain chemotype 
within a dataset which is useful when one requires equal representation of 
chemotypes. This is the case in structure-activity relationship studies where 
overrepresentation of a particular chemotype can lead to bias in results.  
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Clustering methods can be divided into overlapping and non-overlapping methods, 
the most common of which are non-overlapping methods where each molecule 
belongs to a single cluster. With overlapping methods, a single molecule can belong 
to different clusters. Non-overlapping methods can also be divided into two groups: 
hierarchical and non-hierarchical; hierarchical clustering places molecules into 
clusters of increasing size for which dendrograms may be used to visualize (Leach, 
2001). A common method of clustering, agglomerative hierarchical clustering, begins 
with each molecule in its own cluster and progresses by combining the most similar 
structures together until all molecules are placed in one huge cluster (Saeed, Salim, 
& Abdo, 2013) 
There are different methods for calculating the similarity between clusters: single 
linkage, complete linkage or average linkage (Leach & Gillet, 2007). In single linkage 
methods, the distance between clusters is calculated as the minimum distance 
between any two compounds from each cluster. In complete linkage, the furthest 
distance between any two molecules represents the distance between the two 
clusters. The average distance between all pairs of molecules represents the distance 
between clusters in average linkage methods. The assignment of molecules to 
clusters often requires one to make a choice between specifying the number of 
clusters required (less than the number of molecules) and specifying a distance 
threshold (the distance under which molecules are assigned to the same cluster). 
 
1.6. Quantitative structure activity relationships (QSAR) 
A QSAR is a quantitative (mathematical) model that relates structure-derived 
properties of a molecule to its biological activity (Newby, 2014; Yee & Wei, 2012). 
QSAR modelling is based on the similar property principle which states that 
structurally similar molecules have similar biological activity. One advantage of QSAR 
models is that they allow for predictions to be made before a compound is 
synthesized and thus serve as a time and money saving tool in drug discovery (Park 
et al., 2014).  
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Figure 3: The process of creating QSAR models (Newby, 2014) 
As illustrated in Figure 3, the process of developing QSAR models begins with 
collecting data for the property to be modelled. The quality of data is an important 
point for consideration as poor quality data often result in poor models. The next 
step is calculating molecular descriptors which describe the structural information of 
molecules. Various types of molecular descriptors exist and not all are relevant for a 
particular task. Therefore, feature selection is carried out to remove redundant and 
uninformative descriptors. For validation of the model, the dataset is often divided 
into training and test set prior to model development. 
A wide range of QSAR methods for addressing different problems have been 
developed (Hou et al., 2006). QSAR models generally fall into 2 categories: 
regression models and classification models (Leach, 2001). Regression methods aim 
to give a real value output whereas classification methods aim to predict the class or 
group to which molecules belong (e.g. inhibitor or non-inhibitor) (Fujita, 1995). 
Multiple linear regression (MLR) is an example of a continuous model which deduces 
the linear relationship between biological activity (or any property of interest) and 
molecular descriptors. Problems may occur with MLR when the number of 
correlating descriptors increases, thus making efficient feature selection important. 
Artificial neural networks are an example of a classification method, the idea of 
which is inspired by the organisation and functioning of the central nervous system 
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(Hou et al., 2006). Other examples of classification QSARs include Logistic regression, 
Naïve Bayes, and the Random Forest classifiers (Dehmer et al., 2012). 
1.6.1 Data collection and curation 
The process by which a QSAR model is derived can greatly influence its utility as a 
predictive tool. Quality of data used can influence how models perform therefore it 
is important that data is of high quality. It is often the case that data used in QSAR 
model generation is obtained from different sources which makes the curation 
process more important. Curation is carried out to remove errors in the datasets. 
The standardisation of molecular structures is an important step in data curation. 
Incorrect structures can lead to calculation of wrong descriptors and this will 
subsequently render the models less effective if useful at all. The removal of 
duplicate molecules is also important as having duplicates in the model generation 
process can lead to overfitting and artificially high predictions which may not 
translate to external datasets.  
1.6.2 Molecular descriptors 
Mathematical representations of molecular structures, more commonly known as 
molecular descriptors, are used to deduce the relationship between structure and 
biological activity (Newby, 2014). A wide range of molecular descriptors exist ranging 
from experimentally obtained measurements such as solubility and logP to 
theoretically obtained values based on quantum and molecular mechanics 
descriptors. Binary representations of molecular structure more commonly known as 
molecular fingerprints can also be used as molecular descriptors in QSAR modelling. 
The choice of molecular descriptors used depends on the problem to be addressed. 
For example, logP (as a measure of lipophilicity) is often used as a descriptor to 
predict the bioactivity and membrane permeability of molecules. 
1.6.3 Feature selection 
The abundance of descriptors that can be used in QSAR modelling makes it 
necessary to have a method of selecting important descriptors for the problem at 
hand (Eklund, Norinder, Boyer, & Carlsson, 2014; Tuv, Borisov, Runger, & Torkkola, 
2009). Not all descriptors carry necessary information for generating a QSAR model. 
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Three types of descriptors may be found in a descriptor pool: relevant, irrelevant and 
redundant descriptors (Anderson, Michalski, Carbonell, & Mitchell, 1983). Irrelevant 
descriptors are considered unimportant for the problem at hand while redundant 
descriptors are those that carry the same information e.g. highly correlated 
descriptors. Feature selection is the method by which irrelevant and redundant 
descriptors are removed from the descriptor pool to leave just the relevant ones for 
the problem at hand. Descriptor selection may be carried out by filter, embedded 
and wrapper methods. Filter methods rank the descriptors according to some metric 
and removes descriptors that are found to be irrelevant (Eklund et al., 2014). 
Examples of filter methods include the removal of highly correlated and low variance 
descriptors. Wrapper methods combine the learning algorithm with the feature 
selection by searching for subsets of descriptors from the original pool. The best 
subset is the one that produce the learner with the highest predictive accuracy (Tuv 
et al., 2009). Embedded feature selection methods look for the best subset of 
descriptors by embedding the feature selection process in model building (Eklund et 
al., 2014).  
1.6.4 Model building 
For generating a QSAR model, the intended use and purpose of the model have to be 
established. This is an important step that helps in choosing the best method often 
with a trade-off between predictive performance and interpretability (Newby, 2014). 
QSAR models are generally classified into unsupervised and supervised methods.  
Unsupervised methods are so called because the learning process does not require 
one to distinguish between independent and dependent variables. This makes 
unsupervised methods ideal for discovering unknown patterns in a dataset, based on 
the similar property principle as mentioned previously (Dehmer et al., 2012; 
Peironcely, Reijmers, Coulier, Bender, & Hankemeier, 2011). Clustering is an example 
of an unsupervised technique often employed for selecting diverse subsets and for 
splitting datasets into training and test sets for supervised methods (Saeed et al., 
2013). 
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Supervised methods require the dependent and independent variables to be 
distinguished and are more commonly applied in QSAR and ADMET modelling than 
unsupervised methods. Molecular descriptors make up the independent variables 
that are used to predict the dependent variable (biological activity or other property 
of interest). Supervised methods can be further divided into classification or 
regression methods. In classification methods, the predicted variable is categorical 
whereas regression methods predict numerical values (Dehmer et al., 2012; Newby, 
2014). The choice between regression and classification methods depends on a few 
factors such as the intended use of the models and the availability of quality data. 
For example, one may be interested in knowing whether molecules are permeable 
or impermeable and in that case a classification method may be preferable. In 
another instance, one may be interested in predicting the biological activity of a 
molecule and in that case, regression methods may be optimal.  
1.6.5 Model validation 
After models have been generated with the training set, a validation step is required 
to assess the predictive performance of the model on the test set. A measure of 
accuracy is required to assess the performance of QSAR models.  
For regression methods, the Pearson correlation coefficient, r2, is often used to 
measure the linear relationship between experimental and predicted data. 
Measurements such as root mean square error (RMSE) and mean absolute error 
(MAE) are often used to measure the performance of models (Yee & Wei, 2012). 
For classification methods, accuracy statistics may be used to measure model 
performance. These statistics are based on calculating the number of correctly 
classified compounds. The overall classification accuracy measures the number of 
correctly classified compounds. Statistics such as specificity and sensitivity measure 
the classification accuracy associated with different classes. The Cohen’s Kappa 
statistic is often used to measure overall classification accuracy taking into account 
the probability of correct classification by chance (Ben-David, 2008).  
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1.7 QSAR models of cellular permeability 
Predicting ADMET properties of molecules in compound libraries before synthesis is 
the goal of predictive modelling.  Rule based approaches are often used as filters to 
screen out compounds that have small chances of being drugs. An example of a rule 
based approach is Lipinski’s rule of 5 which states that an orally administered drug is 
less likely to be bioavailable if it has molecular weight greater than 500 Daltons, 
more than 5 hydrogen bond donors, more than 10 hydrogen bond acceptors, and a 
logP less than 5. Lipinski, however, states that this rule is not applicable to molecules 
that undergo carrier-mediated transport (Lipinski et al., 2012). Many successful 
drugs have been reported to violate different components of this rule, suggesting 
the rule should be used as a guideline. An example is Talaprevir, a hepatitis C drug 
developed by Vertex. This compound violates all components of the rule of 5 but is 
still active upon oral administration. The rule based approach is oftentimes too 
general therefore necessitating the development of more accurate predictive 
models.  
There is a large number of published articles looking at predicting the permeability 
of compounds using QSAR models (L. Chen, Yao, Yang, & Yang, 2005; Guangli & Yiyu, 
2006; T. Hou et al., 2006; Refsgaard, Jensen, Brockhoff, Guldbrandt, & Christensen, 
2005). Permeability values obtained from in-vitro models of human cell permeability 
can be used to generate predictive QSAR models. One such example is Pham The et 
al. who took a classification QSAR approach to predict Caco-2 cell permeability using 
a dataset of 674 compounds from over 250 published articles (Pham The et al., 
2011). They used DRAGON descriptors (Borota et al., 2011) and linear discriminant 
analysis QSAR (LDA-QSAR) to create 21 predictive models, the best of which was 
built using 9 DRAGON descriptors. The obvious limitation is that there is no attempt 
to clearly distinguish between passive diffusion and carrier-mediated transport in 
the descriptors used. All compounds are either assumed to have the same 
permeation mechanism (passive diffusion) or the descriptors are expected to 
describe both passive diffusion and active transport processes.  
Another Caco-2 model, developed by Guangli & Yiyu (Guangli & Yiyu, 2006), made 
use of descriptors from an open source software, Chemistry Development Kit (CDK), 
31 
 
and the Support Vector Machine (SVM) learning method. The resultant model from 
this study suggests that the number of hydrogen bond donors and properties 
relating to molecular surface area are important determinants of membrane 
permeability. There was a strong correlation between experimental and predicted 
permeability values in the test set (r=0.85) suggesting that the combination of the 
aforementioned descriptors and SVM methods is effective in predicting Caco-2 
permeability coefficients. However, the limitations to this study, like most QSAR 
studies, can be attributed to the methodology applied. A small data set was used, 
rendering the model applicable to a small range of compounds with shared 
structural similarities. They made no use of an external data set in the validation 
step, instead opting to divide their original data set into training and test set. This is 
a major limitation given that the molecules used were obtained from two published 
studies therefore likely to contain a relatively small range of chemotypes. One would 
therefore expect the domain of applicability for such models to be limited.  
Refsgaard et al. also carried out in silico modelling of intestinal membrane 
permeability (Refsgaard et al., 2005). Permeability coefficients of 712 compounds 
were obtained from in vitro MDCK and Caco-2 studies undertaken in a single 
laboratory. In the MDCK assay, permeability was measured in the absorptive 
direction (A-B) and both absorptive and secretory transport were measured in the 
Caco-2 assays. Substrates of efflux transporters were identified and removed from 
the dataset, leaving only molecules that undergo passive diffusion. 9 descriptors 
were chosen to represent lipophilicity, flexibility, hydrogen bonding capability and 
steric properties. The best performing model is reported to have a 15% 
misclassification rate, with no compounds in the non-permeable group being 
misclassified. Despite the low misclassification rate, this study is a good example of 
how passive diffusion is the main focus of QSAR models of permeability and how, in 
some cases, substrates of membrane transporters are excluded from datasets. 
Both passive diffusion and active transport processes are considered important to 
the permeability of compounds. Evidence from published articles suggests that most 
studies do not attempt to distinguish between carrier-mediated transport and 
passive diffusion in QSAR models. Because carrier-mediated transport is important 
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to the permeability of molecules, the accurate modelling of carrier-mediated 
transport is therefore an area which needs addressing. 
 
1.8 Carrier mediated transport descriptors in modelling of cellular 
permeability  
Most predictive modelling studies are focused on describing passive diffusion of 
molecules across cell membranes. This is unsurprising given that it is widely 
perceived that active transport has a small contribution to the ADME properties of 
most drugs compared with passive diffusion. There are also limitations which hinder 
active transport modelling such as availability of structural data and the variation of 
results between different labs. The promiscuity of transporters also hinders the 
process of creating models because of the many possible binding modes and the 
subsequent wide range of features that may render a molecule complementary to 
any given uptake or efflux transporter (Giacomini et al., 2010). Generalizable 
predictive models of active transport are therefore rare, with most studies limited to 
individual transporters (Cabrera, González, Fernández, Navarro, & Bermejo, 2006; 
Sedykh et al., 2013). The permeability glycoprotein (P-gp) is an efflux transporter 
that many studies have focused on (Bikadi et al., 2011; Broccatelli et al., 2011). This 
is most likely because many drug molecules are less efficacious if they are substrates 
of P-gp and therefore early identification of such substrates is important. However, 
most of the studies on single transporters make use of a 3D structure of the 
transporter in order to identify interaction points and create 3D QSAR models (Bikadi 
et al., 2011). QSAR modelling of individual transporters is an alternative for 
predicting compounds likely to interact with a particular transporter. However, 
developing models for all membrane transporters would be time consuming and 
near impossible given the lack of structural data.  
With the use of various learning methods and descriptors from MOE (Chemical 
Computing Group) and DRAGON, Sedykh et al. (Sedykh et al., 2013) created QSAR 
models for use in predicting molecules likely to be transporter substrates. This is one 
of a few reports attempting to model active transport systems collectively instead of 
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focusing on individual transporters. The models generated show high external 
validation (71-100%; 5-fold external validation) and therefore such methodologies 
could be applied in generating descriptors of carrier-mediated transport. 
Recently Dobson et al. (Dobson, Patel, & Kell, 2009) proposed the use of ‘metabolite-
likeness’ as a descriptor of active transport. The authors suggest that drug uptake is 
predominantly an active uptake process and that passive diffusion plays a minimal 
role. This goes against the current belief that passive diffusion is dominant. They 
suggest that endogenous molecules permeate cells through membrane transporters 
and thus molecules that are structurally similar to metabolites will interact with and 
be transported by the same carrier-mediated transporter systems.  If active 
transport is the main method by which molecules permeate the cell membrane and 
metabolite-likeness is a good descriptor of carrier-mediated transport capabilities, 
those metabolites that show little similarity to drugs could provide new avenues for 
drug discovery. Drugs can be designed to be similar to these metabolites and 
consequently bind to membrane transporters that current drugs do not interact 
with. 
 
1.9 Aims & Objectives 
The aim of this project is to develop classification models of molecule permeability 
that include novel descriptors of carrier mediated transport and to evaluate their 
predictive performance. To achieve this aim, a set of standard physicochemical and 
structural property descriptors will be extended by inclusion of two novel descriptors 
based on predicted molecular properties related to cell permeability. Molecular 
similarity to endogenous metabolites and affinity for membrane transporters 
predicted by PIDGIN will be used as carrier mediated transport descriptors. The 
performance of models generated by using an extended set of descriptors will be 
evaluated by comparison to models developed from commonly used descriptors 
such as lipophilicity, solubility and structural keys. 
Specific objectives are: 
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 Assess the applicability of metabolite-likeness as a potential descriptor of 
likelihood of molecules to undergo carrier mediated transport by comparing 
structural similarity of approved drugs and commercially available 
compounds to endogenous metabolites. This objective is addressed in 
Chapter 3.1. 
 Assess the applicability of a target prediction tool, PIDGIN, to predict 
potential substrates of membrane transporters. This objective is addressed in 
Chapter 3.2. 
 Develop classification models of permeability that incorporate the novel 
descriptors and evaluate whether inclusion of novel descriptors improve the 
predictive performance of such models. This objective is addressed in 
Chapter 4. 
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2. MATERIALS AND METHODS 
 
2.1 Software 
A wide range of computational tools were applied to carry out different aspects of 
this study.  The data mining tool, KoNstanz Information MinEr (KNIME) (Berthold et 
al., 2009; Warr, 2012), was used as the main platform for drug discovery and 
development applications. KNIME is a workflow environment that allows integration 
of machine learning, data mining and cheminformatics algorithms, adopting a 
pipeline concept where information flows between nodes connected by edges 
(Figure 4). Many software vendors such as ChemAxon (www.chemaxon.com) and 
RDKit (Riniker & Landrum, 2013; Saubern, Guha, & Baell, 2011) have implemented 
cheminformatics toolkits for use in KNIME. The ChemAxon toolkits were used in this 
study to convert SMILES strings into 2D structures, to carry out structure 
standardization and to calculate molecular descriptors and fingerprints. The RDKit 
toolkit also includes a fingerprint calculator with several different fingerprint types.  
The Waikato Environment for Knowledge Analysis (WEKA) data mining package, 
developed at the University of Waikato, is a collection of machine learning 
algorithms that are useful for predictive modelling (Hall et al., 2009). Included in the 
WEKA collection are Logistic regression, Naïve Bayes and Random Forest classifiers 
for which KNIME nodes have been developed. These classifiers are used in this study 
and are described in detail in later sections. For data analysis and visualisation, 
Spotfire (www.spotfire.tibco.com) and Microsoft Excel were used.  
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Figure 4: An example KNIME workflow illustrating the flow of information between 
nodes through edges 
2.2 Dataset collection and curation 
Simple molecular input line entry system (SMILES) strings of metabolites were 
obtained from the Human Metabolome Database (HMDB) v3.6 (Wishart et al., 2007). 
The data was obtained in an XML format from HMDB. In order to retrieve the 
required information, XSLT files were written to extract the HMDB ID, the SMILES 
string and information regarding the type of metabolite (e.g. endogenous, drug or 
food metabolite). The database contained a total of 41514 metabolite structures. 
Metabolites in this database were labelled according to the source from which they 
are derived. Included in the database are metabolites from plant sources (53), 
microbial metabolites (18), food metabolites (5819), drug metabolites (909), drugs 
(1509) and toxin/pollutant metabolites (43). 5653 metabolites were unlabelled.  
SMILES strings of Food and Drug Administration (FDA) approved drugs were 
obtained from DrugBank (Wishart, 2006). The database contained 7759 molecules, 
both small molecule and biotech drugs, labelled as either withdrawn, nutraceutical, 
investigational, illicit, experimental, or approved. Of particular interest to this study 
were orally administered small molecule drugs. All other compounds with labels 
such as investigational-withdrawn, biotech, nutraceutical etc. were removed from 
the approved drugs list. The chemical structures of 100 000 commercially available 
compounds were obtained from the proprietary Evosource library (Evotec UK Ltd). 
For the main purpose of this study, to evaluate whether the inclusion of carrier-
mediated transport descriptors improves the predictive accuracy of permeability 
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predictions, a dataset containing 969 unique compounds with experimentally 
determined caco-2 apparent permeability (Papp) values in both apical to basolateral 
(A-B) and basolateral to apical (B-A) directions was provided by the DMPK group at 
Evotec.  
It is often the case that experimentally obtained values are numerical. In 
classification QSAR methods, it is necessary to define thresholds in order to assign 
molecules into binary classes. Three classification schemes were applied for 
compounds in the caco-2 dataset. Caco-2 permeability cut-off values were applied in 
both A-B and B-A directions. Compounds were assigned to the “permeable” class in 
both directions if Papp ≥ 5 × 10-6 cm/s whereas “non-permeable” was defined for 
compounds with Papp ≤ 1 × 10-6 cm/s. Molecules with efflux ratio (Papp (B-A)/Papp (A-B) ≥ 
10 were classed as “high efflux” whereas compounds with efflux ratio ≤ 1 were 
classed as “low efflux.”  
In drug discovery, the objective is to develop QSAR models that are generalizable to 
many chemotypes. A generalizable model is one that is capable of predicting the 
relevant property of a novel molecule despite the chemotype. The 
overrepresentation of a particular chemotype or chemical series in a training set can 
lead to overfitting the model. This can have major influences on the overall 
performance of any model when it comes to predicting molecules from different 
chemotypes. We therefore hypothesize that having a representative set of 
compounds for each chemotype can give a better outlook at how the model is likely 
to perform when used to predict molecules from chemotypes that are unrelated to 
the training set chemotype. This model is likely to be more generalizable as it avoids 
over-fitting the model to a particular chemotype.  
To analyse this, compounds in the caco-2 dataset were clustered and the centroid 
molecule from each cluster was used for subsequent QSAR model generation. The 
first step in the clustering process was to create a distance matrix from the 
fingerprints of each molecule using the Distance Matrix calculate node in KNIME. The 
commonly used extended connectivity fingerprint (ECFP) fingerprint encoding was 
used in this case. The ECFP takes into account the environment of each atom in a 
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molecule by encoding the neighbouring atoms of each individual atom up to a 
predefined diameter.  
A distance matrix can be used for hierarchical clustering. The assignment of 
molecules to clusters requires the user to choose between a specific number of 
clusters or a distance threshold under which compounds are assigned to the same 
class. A threshold was chosen to ensure that a reasonable proportion of clusters 
contained compounds from the same class. The distance threshold selected was 0.3 
and this means molecules that are within a distance of 0.3 from each other are 
assigned to the same class. Some clusters will contain more compounds than other 
clusters but the fact that a centroid molecule will be selected means that each 
cluster is equally represented. 
Due to the majority of approved drugs being small molecules (Wishart et al., 2007), 
1000 Daltons was set as the maximum molecular weight for any compound in the 
approved drug, metabolite and library compound dataset. A minimum molecular 
weight of 150 Daltons was also applied to the same datasets. This constraint was 
applied to remove ions and to ensure the inclusion of only small organic molecules 
containing at least 5 atoms. While this process reduces the chemical space covered, 
it ensures that the distribution of molecular weight across the datasets is the same. 
This is particularly important in this study as molecular fingerprints are employed for 
calculation of similarity between compounds from different datasets. The presence 
or absence of certain chemical substructures will be used to determine structural 
similarities. Fingerprint-based similarity measures are size dependant because large 
compounds are likely to have more substructures while small molecules have fewer 
substructures. In a molecular fingerprint, the presence or absence of a substructure 
in a molecule is indicated by setting the relevant bit to 1 or 0 (Holliday, Salim, 
Whittle, & Willett, 2003). Large molecular weight molecules are more likely to have 
more bits set to 1 because they contain more substructures and are therefore more 
likely to have artificially high similarity values to smaller molecules. Holliday et al. 
analysed the effects of molecular size on various similarity coefficients when used to 
measure the structural similarity between pairs of molecules and came to the 
conclusion that bit density affects similarity measures (Holliday et al., 2003).  
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Standardization of structures in all datasets was carried out using the Chemaxon 
Standardizer tool which is available as a KNIME node. The process of standardisation 
was carried out as suggested by Dobson et al.(Dobson et al., 2009) and involves 
aromatization, removal of salts, selection of the largest fragments and 
standardization of stereochemistry. The standardization of molecular structures is an 
important process that ensures that the same molecule can be recognised when 
represented by different chemical forms (Figure 5).  
 
   
Figure 5: An illustration of how the same molecule can have different chemical 
representations. 
 As we are interested in the behaviour of molecules in biologically relevant 
environments, it is essential to use the biologically relevant representations. In all 
datasets, the most prevalent species at pH 7.4 was calculated and retained using the 
Major Microspecies at pH 7.4 node in KNIME. This represents the molecule that is 
most prevalent under biological conditions. The last step in the pre-processing step 
was the removal of duplicates. The GroupBy node was used for this purpose.   
2.2.1 Summary of datasets 
After the manual curation process the datasets contained 93 617 commercially 
available compounds (Evosource), 1349 small molecule FDA approved drugs and 24 
113 HMDB endogenous metabolites. The caco-2 permeability dataset contained 969 
compounds with experimentally determined Papp values in both A-B and B-A 
directions. 
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2.3 Molecular descriptors 
2.3.1 Physicochemical and Structural Property Descriptors 
In QSAR modelling, it is important to select descriptors that are relevant to the 
biological process under consideration. A series of Chemaxon descriptor calculators 
were used to generate molecular descriptors of the compounds in the caco-2 
permeability dataset. Basic molecular values related to the elemental composition of 
the molecule were calculated by the Elemental Analysis node. For example, the 
molecular weight of each molecule was calculated using the Elemental Analysis 
plugin. Characteristic values related to the topological structure of the molecules 
were calculated using the Topology Analysis node. Hydrogen bond donor and 
acceptor counts were calculated using the H Bond Donor/Acceptor node. The pKa 
values were calculated using the pKa calculator plugin which calculates the pKa 
values of all atoms that can lose or gain a proton based on the distribution of partial 
charges. Molar Refractivity values were calculated using the molar refractivity node. 
LogD, logP, polar surface area (PSA) and molecular surface area were also calculated. 
Solubility coefficients of each molecule were calculated using MOE descriptors 
because of lack of a license for the relevant ChemAxon tool. MACCS keys counts 
were also generated for each of the compounds in the dataset. There are a large 
number of possible molecular descriptors that could have been calculated. One of 
the objectives of QSAR modelling is to ensure model interpretability. Therefore, the 
majority of descriptors that are difficult to interpret were not considered for 
predicting the permeability of compounds in a caco-2 cell.  
To summarise, the descriptors calculated include size descriptors (molecular weight), 
lipophilicity (logP and logD) protonation descriptors (pKa), aqueous solubility (logS), 
geometrical descriptors (topology, molecular surface area & polar surface area), and 
structural descriptors (166 MACCS keys).  
2.3.2 Novel Descriptors of Carrier-Mediated transport 
In order to evaluate whether the inclusion of descriptors of carrier mediated 
transport can improve the performance of QSAR models of caco-2 permeability, 
there is a need for novel descriptors of carrier mediated transport. The two potential 
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sources of general descriptors of carrier-mediated transport pursued in this study 
are the concept of metabolite-likeness and the availability of a target prediction tool 
PIDGIN. The term ‘potential sources’ has been used on purpose to signal that these 
are not approved sources but they have the potential to serve as source descriptors 
of carrier-mediated transport and their utility for such will be investigated. Target 
prediction tools can be considered a good source of carrier-mediated transport 
descriptors if the tool has sufficient models of membrane transporters. The majority 
of studies are currently looking at predicting the likelihood of a molecule binding to a 
specific membrane transporter. For example, the permeability glycoprotein (P-gp) is 
a commonly known membrane transporter that is involved in the efflux of many 
compounds. For this reason, many seek models to predict the likelihood of 
molecules binding to P-gp in order to avoid those particular compounds as they are 
likely to be ineffective because they are removed from the cell. Here, we seek a 
general descriptor of carrier-mediated transport that can be utilised as an attribute 
or descriptor for the purposes of QSAR studies.  
2.3.3 Metabolite-likeness as a descriptor of carrier-mediated transport 
To assess the metabolite-likeness of approved drugs, various fingerprints of 
compounds from the endogenous metabolite and approved drug datasets were 
generated using the RDKit Fingerprint calculator node in KNIME. The choices of 
fingerprints available include connectivity fingerprints (Morgan and FeatMorgan), 
atom-pair fingerprints (Atom-Pair), topological torsion fingeprints (Torsion, RDKIT), 
avalon and substructure based fingerprints (Layered and MACCS keys). All fingerprint 
types were calculated and for each fingerprint, the Tanimoto similarity of each 
approved drug to each metabolite was calculated using a fingerprint similarity 
calculator node in KNIME. The Tanimoto coefficient is calculated as follows:  
𝑇(𝑎, 𝑏) =
𝑁𝐴&𝐵
𝑁𝐴+ 𝑁𝐵− 𝑁𝐴&𝐵
  
where 𝑇(𝑎, 𝑏) represents the Tanimoto similarity between compounds a and b, 
𝑁𝐴&𝐵 represents the number of on bits in common, 𝑁𝐴 represents number of on bits 
in compound a and 𝑁𝐵 represents the number of on bits in compound b. As a result, 
the Tanimoto similarity between any pair of compounds is always between 0 and 1, 
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1 meaning very similar. Each molecule from the drug set was compared to each 
metabolite (Figure 6) and the highest Tanimoto coefficient for each drug was 
retained as a possible descriptor termed the nearest metabolite Tanimoto similarity 
(NMTS) (Appendix Figure A. 1). 
 
Figure 6: Illustration of fingerprint based metabolite similarity calculation 
For the purpose of selecting the most appropriate fingerprint for this new descriptor, 
the metabolite-likeness of approved drugs and commercially available compounds 
was investigated with substructural (MACCS keys) and Chemaxon connectivity 
fingerprints (ECFP with diameter of 4 and Chemical Fingerprint). The commercially 
available compound dataset (Evosource) represents the general chemical space 
considered in drug discovery projects. If approved drugs owe their success to their 
metabolite-likeness, we hypothesize that the chemical space occupied by Evosource 
compounds should not be closer than the drug space to the metabolite space.  
For each fingerprint encoding, the Tanimoto similarity of each approved drug and 
library compound to each endogenous metabolite was calculated as mentioned 
above (Appendix Figure A. 1). Because the number of library compounds (93617) far 
exceeds the number of approved drugs (1349), 1000 samples of 1400 randomly 
selected commercial compounds were taken to roughly match the number of 
approved drugs. The percentage of approved drugs and the average percentage of 
library compounds (from the 1000 samples) above given NMTS threshold values 
were calculated. We hypothesize that approved drugs are more similar to 
endogenous metabolites. 
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2.3.4 Target prediction as a source of descriptors of carrier-mediated 
transport 
PIDGIN (Prediction IncluDinG INactivity) is a Bernoulli Naïve Bayes algorithm based 
target prediction too l(Mervin et al., 2015). The models are based on activity data 
obtained from ChEMBL(18) and inactivity data from PubChem. The models were 
trained and evaluated by a 5-fold cross validation, achieving an average recall and 
precision of 67.7% and 63.8% for active compounds and 99.6% and 99.7% for 
inactive compounds. Compared to models based on active data alone, inclusion of 
inactivity data is reported to produce models with better recall and precision. The 
PIDGIN tool was therefore used in this study to predict membrane transporter 
targets for compounds in the caco-2 dataset. The PIDGIN tool was made available as 
a node in KNIME by the computational chemistry group at Evotec. 
For the purpose of this study, an indication of the abundance of membrane 
transporter models included in the PIDGIN tool was required. It is also important to 
know which transporters are expressed and function in caco-2 cells. A caco-2 gene 
expression profile was obtained from the Gene Expression Omnibus (GEO) 
database(D. Sun et al., 2002) in a format compatible with Microsoft Excel (csv). Gene 
expression data was presented as robust multi-array (RMA) values which are log2 
quantile normalised. Quantile normalisation is a statistical method for making two 
distributions identical for ease of comparison. The dataset also contained gene 
codes. Because the RMA values can range between 4 and 13, it was necessary to 
define an RMA threshold value above which the relevant protein can be considered 
sufficiently expressed and functional in the cell.  
In this study, the minimum RMA gene expression value was calculated as: 
𝑚𝑖𝑛𝑖𝑚𝑢𝑚 𝑒𝑥𝑝𝑟𝑒𝑠𝑠𝑖𝑜𝑛 𝑣𝑎𝑙𝑢𝑒 = 𝑚𝑒𝑑𝑖𝑎𝑛 𝑒𝑥𝑝𝑟𝑒𝑠𝑠𝑖𝑜𝑛 + 1 
Because the expression values are log2 transformed, adding a value of one to the 
median expression value means the minimum expression threshold is double the 
median expression value. 
After removal of genes below the minimum expression value, the next step was to 
perform a reference filter to investigate which of the expressed genes encode 
membrane transporters. Uniprot Accession numbers and gene codes of human 
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membrane transporters were obtained from UniProt (Magrane & Consortium, 2011). 
With reference to gene codes, the UniProt Accession numbers of sufficiently 
expressed human membrane transporters were obtained and matched against 
Accession numbers from the PIDGIN tool. All but membrane transporter prediction 
models were removed from the output. This output was in binary format, 0 
indicating non-substrate and 1 indicating non-substrate of the relevant transporters. 
Molecules from the Caco-2 dataset compounds were used as input for the PIDGIN 
tool. 
2.3.5 Descriptor normalization 
After calculation of molecular descriptors, descriptor normalization was carried out. 
As descriptors have substantial differences in their ranges and values, it is essential 
to carry out a normalization procedure to ensure equal weighting of descriptors 
(Faulon & Bender, 2010). Examples of descriptor normalization methods include 
min-max normalization, Z-score normalization and normalization by decimal scaling 
(Patro & Sahu, 2015). For the purposes of this study, min-max normalization was 
carried out to perform a linear transformation of all values such that the minimum 
and maximum values of each descriptor range between 0 and 1. The formula for a 
min-max normalisation is: 
𝑥′ =  
𝑥 − min (𝑥)
max(𝑥) − min (𝑥)
 
Where x’ is the rescaled value, x is the original value, max (x) is the original maximum 
value and min (x) is the original minimum value (Patro & Sahu, 2015).  
2.3.6 Feature selection 
The initial descriptor pool contained over 200 descriptors. Different approaches to 
reduce dimensionality and redundancy in the descriptor set were taken for each 
QSAR classifier. Molecular descriptors with similar values between molecules (low 
variance descriptors) do not carry useful information. The variance of each 
descriptor was calculated and descriptors with variance below 0.1 were removed 
from the dataset. As variance is range dependant, it is important to carry out 
descriptor normalization before applying a variance filter. 
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After removing descriptors with low variance, highly correlated descriptors were 
removed from the dataset. A correlation filter was used to remove descriptors 
carrying the same information. Here we calculate the correlation coefficient 
between descriptors as Pearson’s Product Moment Coefficient (r) and set a 
threshold of 0.85. For Naïve Bayes and Random Forest algorithms, low variance and 
correlation filter methods were applied. The correlation filter of 0.85 retained 144 
descriptors including MACCS keys, physicochemical and the novel descriptors of 
carrier mediated transport.   
Backward feature selection was used to select important descriptors, from the 144 
descriptors, for the Logistic regression classifier (Appendix Figure A. 2). The 
backward feature selection for Logistic regression was performed three times to 
select important descriptors for A-B permeability classification, B-A permeability 
classification and efflux ratio classification. In this method, the classification 
algorithm is trained on the initial n (144) input features (descriptors), then removes 
one input feature at a time and trains the same model on n-1 input features n times.  
The input feature whose removal has produced the smallest increase in the error 
rate is removed, leaving n-1 input features. The process is then repeated using n-2 
input features, and so on. Each iteration k produces a model trained on n-k input 
features and an error rate e(k). Selecting the maximum tolerable error rate, we 
define the smallest number of features necessary to reach that classification 
performance with Logistic regression. For the purpose of this study, the smallest 
subset of descriptors that produce an error rate below 0.1 was chosen.  
 
2.4 Development of QSAR models of Caco-2 permeability 
2.4.1 Classification Accuracy and Cohen’s Kappa calculation 
Overall classification accuracy can be defined as the proportion of correctly classified 
instances. It is calculated as: 
𝐴𝑐𝑐𝑢𝑟𝑎𝑐𝑦 =  
𝑇𝑃 + 𝑇𝑁
𝑇𝑃 + 𝐹𝑃 + 𝐹𝑁 + 𝑇𝑁
 
Where TP is number of true positives, TN is number of true negatives, FP is the 
number of false positives and FN is the number of false negatives. A positive 
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classification is user defined and in this case, Permeable and low efflux are defined 
as positives whereas non-permeable and high-efflux are defined as negatives. This 
means that a true positive or true negative classification corresponds to a compound 
that is correctly classified. A false positive is a misclassification where a negative is 
classified as positive and a false negative classification occurs when a positive is 
classified as negative. The possible outcomes of a classification problem can be 
described using a confusion matrix (Figure 7). 
 
 
Figure 7: Confusion matrix illustrating the possible outcomes of a classification 
problem 
Cohen’s kappa  is a statistic used in this study to measure the level of agreement 
between the actual class and the predicted class of compounds taking into account 
the likelihood of random agreement (Cohen, 1968). Cohen’s kappa is calculated as: 
𝐾 =  
𝑃0 −  𝑃𝑒
1 −  𝑃𝑒
 
Where P0 is the observed agreement between actual and predicted class and Pe is 
the probability of random agreement between the actual class and the predicted 
class. 
2.4.2 Training and validation sets 
Instead of using a single split to create a training and validation set, the 5-fold cross 
validation technique was employed in the model building and validation procedure 
to evaluate the performance of models. This technique therefore requires the 
training of multiple models (5 models in a 5-fold cross validation). The dataset is split 
into 5 subsets of equal size and the following and each subset is used as the 
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validation set once and as part of the training set four times. This means each 
compound in the dataset is predicted once and used to train the model four times. 
2.4.3 Convergence calculation 
1000 iterations of the 5-fold cross validation technique was repeated using Logistic 
regression classifier. A cumulative moving average plot of A-B permeability 
classification accuracy was generated. The number of iterations after which the 
moving average accuracy converges was employed as the number of iterations to be 
performed for any subsequent models generated in this study. 20 iterations of the 5-
fold cross validation procedure were performed for each QSAR model generation 
and validation.   
 
For the purposes of this study, Logistic regression, Naïve Bayes and Random Forest 
classifiers were used. These methods are briefly described below. For each of these 
three classifiers, 3 datasets were generated. These datasets are the same apart from 
the set of descriptors used. In the standard descriptor dataset, descriptors that are 
considered relevant for studying drug cellular permeability were included. The 
second dataset consists of these standard descriptors and nearest metabolite 
Tanimoto similarity (NMTS) of each of the Caco-2 dataset compounds. The third 
dataset consists of standard and PIDGIN descriptors. Compounds were labelled as 
either permeable or non-permeable in both Apical to Basolateral and Basolateral to 
Apical directions. Furthermore, compounds were labelled as being high or low efflux 
according to the classification criteria previously described. 
2.4.4 Logistic Regression Classifier 
Logistic regression employs the concept of regression to perform binary 
classifications (Yee & Wei, 2012). The nature of the logistic function ensures that 
values obtained are between 0 and 1. The output can be transformed into a binary 
response based on a threshold value, in this case 0.5. This means any output greater 
than 0.5 is transformed to 1 and below 0.5 is transformed to 0.  
The regression model is then generated as: 
𝐿𝑜𝑔𝑖𝑡 (𝑃) = 𝑏0 + 𝑏1𝑥1 + 𝑏2𝑥2 … +  𝑏𝑘𝑥𝑘  
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Where Logit (P) is the logit transformation of the probability of one of the outcomes, 
𝑏0, 𝑏1 … 𝑏𝑘 are regression coefficients and 𝑥1, 𝑥2 … 𝑥𝑘  are molecular descriptors. The 
Logistic regression classifier was implemented in KNIME as illustrated in Figure 8. 
 
Figure 8: Logistic regression classification model development in KNIME 
 
2.4.5 Naïve Bayes Classifier 
Naïve Bayesian classifiers are based on the Bayesian theory of probability. Given a 
dataset with instances to be classified or in this case molecules to be classified 
according to their permeability or efflux ratio, Naïve Bayesian classifiers takes into 
account the prior probability of the molecule belonging to each of the classes. From 
this, the posterior probability can be calculated. The compound belongs to the class 
for which its posterior probability is greater than 0.5 (Yee & Wei, 2012). The 
equation for the Naïve Bayes classifier implemented in the WEKA package is as 
follows: 
𝑃(𝐴|𝐵) =
𝑃(𝐴)𝑃(𝐵|𝐴)
𝑃(𝐵)
 
Where P(A) is the prior probability of A (in this case it is the prior probability of a 
molecule being either permeable or low efflux), P(B|A) is the probability of B given A 
and P(B) is the probability of B (the descriptors). The Naïve Bayes classifier was used 
in this study as illustrated in Figure 9. 
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Figure 9: Naïve Bayes classification model development in KNIME 
2.4.6 Random Forest Classifier 
A Random forest classifier is based on an ensemble of decision trees. One advantage 
of Random forest classifiers is their inherent ability to handle high dimensional data 
(Svetnik et al., 2003). However, this has been reported to come at the cost of 
classification accuracy. In a 5 fold cross-validation, for each fold, a random forest of 
10 trees is constructed. In the WEKA implementation, each tree is constructed while 
considering only 8 random descriptors from the available set of descriptors. The 
relevant descriptors of the test set compounds are passed through each tree and 
probabilities are calculated. Each compound is predicted to be in a particular class 
and if the probability is greater than 0.5, it belongs to that particular class. If the 
probability is lower than 0.5, it belongs to the other class. This means that the 
molecule belongs to the class for which its probability is greater than 0.5. As 10 trees 
are created, the compound’s class is predicted 10 times. This means that the 
compound belongs to the class it is predicted to belong the most. For example, if a 
compound is predicted to be permeable by 6 trees and non-permeable by 4 trees, it 
belongs to the permeable class of compounds. The Random Forest classifier was 
implemented in this study in KNIME as illustrated in Figure 10. 
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Figure 10: Random Forest classification model development and validation in KNIME 
 
2.5 Statistical analysis of models and descriptors 
2.5.1 Comparison of model performance 
In order to evaluate whether active transport descriptors add value in terms of 
predictive accuracy and Cohen’s kappa, independent samples t-tests were 
performed to compare the average accuracy and kappa of models generated from 
standard descriptors and the novel descriptors. The Independent samples t-test 
generates significance (p) values which are used in this study to evaluate significant 
differences between mean accuracy and Cohen’s Kappa values. Figure 11 shows a 
schema of how this method was implemented in this study. 
 
Figure 11: Schema for generating and comparing performance of models 
2.5.2 Descriptor randomization 
Each descriptor was randomized in turn in order to identify the descriptors that 
contribute the most to model performance. The classification accuracy of models 
when none of the descriptors are randomised is calculated. The non-randomised 
mean classification accuracy of models is then compared to the mean accuracy when 
each individual descriptor is randomised. An independent samples t-test was carried 
out to compare the means. Because of the number of comparisons to be made 
(equal to the number of descriptors), the problem of multiple comparisons arises. 
The Bonferroni’s correction for multiple comparisons was therefore applied (Rafter, 
Abell, & Braselton, 2002).  
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Other methods such as simply leaving one descriptor out could be used but this can 
have an effect on the model performance simply because of an unequal number of 
descriptors. Another approach is to replace each descriptor with a random variable. 
This approach was not taken as the distribution of values cannot be maintained. The 
problem of multiple comparisons has to be addressed. Instead of using the 
significance (p) value of 0.05, the Bonferroni’s critical value can be used. The 
Bonferroni critical value was calculated as α/n where α is the significance level 
applied for the independent samples t-test and n is the number of comparisons to be 
made (equal to the number of descriptors). 
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3. NOVEL DESCRIPTORS OF CARRIER MEDIATED TRANSPORT 
 
3.1 Analysis of Metabolite-likeness 
3.1.2 Results and Discussion  
It has been proposed that structural similarity to endogenous metabolites can be 
used to measure the likelihood of molecules undergoing carrier mediated transport 
(Dobson et al., 2009). Endogenous metabolites are often substrates of membrane 
transporters. It was therefore hypothesized that approved drugs are successful 
because they can permeate the cell via membrane transporters. The structural 
similarity of approved drugs to endogenous metabolites, using various fingerprints 
available in the RDKit  fingerprint calculator, was assessed and results are shown in 
Figure 12. 
 
Figure 12: Percentage of approved drugs above a given NMTS threshold  
 
The different fingerprint encodings produce different percentages of drugs above a 
given nearest metabolite threshold (NMTS). Drugs tend to show higher structural 
0
10
20
30
40
50
60
70
80
90
100
0 0.2 0.4 0.6 0.8 1
%
 a
b
o
ve
 t
h
re
sh
o
ld
NMTS threshold
Pattern
AtomPair
Torsion
RDKit
MACCS
Avalon
Layered
FeatMorgan
Morgan
Fingerprint 
type
53 
 
similarity to metabolites when structures are encoded by structural keys fingerprints 
such as the Pattern, Layered and MACCS keys fingerprints. On the other hand, drugs 
appear less similar to metabolites when connectivity fingerprints such as Morgan, 
Torsion and FeatMorgan fingerprints are used. Around 98% of approved drugs are 
shown to have a nearest metabolite Tanimoto similarity greater than 0.5 when 
encoded by MACCS keys fingerprints (Figure 12).  This is a larger percentage 
compared to the 90% observed by O’Hagan et al. (O′Hagan, Swainston, Handl, & Kell, 
2014) and the difference is most likely because a different set of metabolites was 
used in this study. Considering that 24113 endogenous metabolites were used in this 
study and 1113 in the study by O’Hagan et al., it is unsurprising that the results of 
this study suggest a greater similarity of approved drugs to endogenous metabolites. 
Despite the differences between the studies, the same conclusions can be made: 
approved drugs are structurally similar to endogenous metabolites and the level of 
similarity depends on the fingerprint encoding used.  
The similarity is much greater with structural keys compared with other types of 
fingerprints. This means that drugs are more similar to endogenous metabolites in 
terms of the substructures they contain but less similar when connectivity is taken 
into account.  The findings of this study are in agreement with the idea that, for 
some molecules, the process of drug development is such that they are shifted 
towards the chemical space occupied by metabolites(Khanna & Ranganathan, 2011; 
Peironcely et al., 2011). O’Hagan et al. suggest that this process renders the drug 
more likely to interact with membrane transporters that transport the relevant 
endogenous metabolites. Metabolite-likeness could therefore be a useful descriptor 
of carrier-mediated transport for the purposes of QSAR studies of membrane 
permeability. However, it is not enough to say that approved drugs are similar to 
endogenous metabolites as chemical similarity is context dependent (Mestres & 
Maggiora, 2006).  
Here, only the chemical space occupied by approved drugs is considered. It is also 
necessary to assess the metabolite likeness of molecules that span the general 
chemical space considered in drug discovery projects. Commercially available 
molecules are one such source. If metabolite likeness is a criterion to be used in the 
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enrichment of drug discovery libraries and if the drug development processes 
resembles a shift in chemical structure to that occupied by metabolites, we should 
be able to see significant differences in the metabolite likeness of approved drugs 
and commercially available compounds.   
 
 
Figure 13:  Comparison of percentage of approved drugs and library compounds that 
are above the specified NMTS threshold in the MACCS keys descriptor space. Bars 
representing percentages of Evosource compounds have standard error bars 
attached. These may not be visible because the standard error values are miniscule. 
At all given NMTS thresholds (0.5-1.0), approved drugs are significantly more similar 
to endogenous metabolites than library compounds when the MACCS keys 
fingerprint encoding is used (Figure 13). 98% of approved drugs have a Tanimoto 
similarity greater than 0.5 compared with 95% of library compounds. Of the 
approved drugs, 88% have a NMTS value greater than 0.6 in contrast to the 65% of 
Evosource compounds. The reduction in percentages is greater for Evosource 
compounds than approved drugs. This suggests that there are about 12% of 
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approved drugs that are less similar to endogenous metabolites than 65% of library 
compounds. 
Considering that 95% of commercially available compounds have an NMTS value 
above the 0.5 threshold suggested by O’Hagan et al. (O′Hagan et al., 2014) (Figure 
13), the rule of 0.5 does not appear to be a useful criterion in distinguishing 
successful drugs from molecules from the general chemical space. However O’Hagan 
et al. did acknowledge that molecules that obey the rule will not necessarily be 
successful drugs (O′Hagan et al., 2014). The conclusion was that those that do not 
obey the rule are unlikely to be successful. This could be seen as misleading because 
the majority of compounds in the non-drug or library compound space also obey the 
rule. At higher NMTS values however, a greater separation between approved drugs 
and library compounds can be seen. This suggests that not all but a high proportion 
of approved drugs are more similar to endogenous metabolites than library 
compounds in the MACCS keys descriptor space. 
 
Figure 14: Comparison of percentage of approved drugs and library compounds that 
are above the specified threshold with Chemical Fingerprint encoding. Bars 
representing percentages of Evosource compounds have standard error bars 
attached. These may not be visible because the standard error values are miniscule. 
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A similar trend to that observed when MACCS keys fingerprints are used is also 
observed with the path based Chemaxon fingerprint. Between thresholds 0.1–0.3, 
the percentage of Evosource compounds is greater than that of approved drugs 
(Figure 14). This suggests that there are a few approved drugs that do not resemble 
endogenous metabolites. This is probably due to the inclusion of non-bioactive 
molecules in the list of approved drugs e.g. the diagnostic agent perflutren. 
However, these similarity values are too low for conclusions to be drawn. At higher 
NMTS thresholds (> 0.5), the differences become apparent. For example, more than 
70% of drugs have a NMTS greater than 0.5 compared with about 50% of Evosource 
compounds. The overall trend shows that a higher number of approved drugs have 
greater similarity to endogenous metabolites compared with library compounds.  
 
Figure 15: Comparison of percentage of approved drugs and library compounds that 
are above the specified NMTS threshold with Extended Connectivity Fingerprint 
encoding. Bars representing percentages of Evosource compounds have standard 
error bars attached. These may not be visible because the standard error values are 
miniscule. 
When the circular connectivity (ECFP_4) fingerprint is used, approved drugs still 
appear more similar to endogenous metabolites compared with Evosource 
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compounds (Figure 15). However, the level of similarity is greatly reduced with the 
fingerprint encoding. 98% of approved drugs have NMTS greater than 0.5 with 
MACCS keys, around 70% with ChemicalFP, and 20% with ECFP_4. The most likely 
reason is that ECFP_4 encodes more chemical information by representing the 
presence or absence of particular substructure and their connectivity (Rogers & 
Hahn, 2010a). 
3.1.3 Conclusions of Metabolite likeness 
The nearest metabolite similarity values of both approved drugs and commercially 
available compounds differ with each of the three fingerprint encoding methods. 
However, approved drugs are consistently more similar to endogenous metabolites 
than are library compounds despite the fingerprint encoding. This suggests that 
approved drugs are generally more similar to endogenous metabolites than 
compounds spanning the general chemical space considered in drug discovery. Since 
molecular structure can be captured in several ways (Dobson et al., 2009), the three 
methods used to represent molecular structure and calculate molecular similarity 
show that metabolite-likeness is not just relevant to a particular structural encoding 
but is applicable to all the chemical spaces considered. This finding is in agreement 
with that of Dobson et al. (Dobson et al., 2009) who came to the same conclusion 
that approved drugs are more similar to endogenous metabolites than compounds 
found in typical screening libraries, despite the descriptor space considered. Because 
endogenous metabolites are often substrates of membrane transporters, it is 
reasonable to assume that molecules that are similar to endogenous metabolites are 
likely to undergo carrier-mediated transport. It was therefore hypothesize that 
metabolite-likeness can be used as a descriptor of a molecule’s likelihood to undergo 
carrier-mediated transport. NMTS is therefore used in this study as a novel 
descriptor of carrier mediated transport. 
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3.2 Assessing applicability of PIDGIN, a Target Prediction Tool  
The PIDGIN (Mervin et al., 2015) target prediction tool (described in detail in the 
methods section) was used to predict substrates of membrane transporters in the 
caco-2 dataset. As mentioned in the methods section, it was important to investigate 
which membrane transporters are expressed in caco-2 cells for which models are 
available in the tool. This section aims to give details of that investigation.  
The majority of studies of this nature are differential expression studies aiming to 
identify differentially expressed genes between cells of interest e.g. normal and 
diseased cells (Hayeshi et al., 2008; Siissalo et al., 2007). Not many studies have 
pursued a minimum expression threshold and the reasons for this are wide ranging. 
One reason is that gene expression is a dynamic process which makes the process of 
choosing a minimum expression threshold difficult. Another difficulty stems from the 
fact that gene expression does not always correlate with protein levels.  
However, a publication was found that carried out a similar study and came up with 
the idea of using the median of all expression values as the minimum detection 
threshold (Jin & Wang, 2009). 
3.2.2 Results and Discussion  
A minimum expression threshold robust multi-array (RMA) value of 6.5 was applied. 
Above this threshold, membrane transporters are considered sufficiently expressed 
and therefore more likely that the membrane transporters encoded function in 
Caco-2 cells. Below this threshold, we assume membrane transporters are not 
sufficiently expressed and therefore exhibit no function in caco-2 cells. 
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Table 1: Membrane transporters expressed in caco-2 cells with models available in 
PIDGIN 
Uniprot 
Accession 
Protein Names 
Caco-2 RMA 
expression value 
P49281 
Natural resistance-associated macrophage protein 2 
(NRAMP 2)/(Solute carrier family 11 member 2) 
9.16 
P53985 
Monocarboxylate transporter 1 (MCT 1) (Solute carrier 
family 16 member 1) 
7.62 
P19634 
Sodium/hydrogen exchanger 1 (APNH) / (Solute carrier 
family 9 member 1) 
7.01 
P31645 
Sodium-dependent serotonin transporter (5HT 
transporter) (5HTT) (Solute carrier family 6 member 4) 
6.81 
Q9UNQ0 
ATP-binding cassette sub-family G member 2 (Breast 
cancer resistance protein) 
6.68 
P33527 
Multidrug resistance-associated protein 1 (ATP-binding 
cassette sub-family C member 1) 
6.64 
 
Only 6 PIDGIN models appear to be membrane transporter models that are 
expressed in the caco-2 cells according to the minimum expression RMA threshold of 
6.5 (Table 1).  It must be acknowledged that this is not an exhaustive list of 
membrane transporters and probably does not resemble the abundance of 
membrane transporters in caco-2 cells. Some of these are ion and metal transporters 
which may not be relevant to the transport of drug like molecules e.g. Natural 
resistance-associated macrophage protein 2 (NRAMP 2) and sodium/hydrogen 
transporter (APNH)(Cingolani & Ennis, 2007; Nevo & Nelson, 2006).  
The Monocarboxylate transporter 1 (MCT1) is reported to transport short chain 
monocarboxylates and fatty acids. This means the protein is likely to be involved in 
the transport of small molecules that are of relevance to drug discovery. A study by 
Okamura et al. (2001) concerned with the uptake of nataglinide, an oral 
hypoglycaemic agent, in caco-2 cells suggests that MCT1 is indeed expressed and 
functions in caco-2 cells(Okamura, Emoto, Koyabu, Ohtani, & Sawada, 2002). This 
study also suggests that MCT1 is relevant to the transport of small molecules that 
are pursued in drug discovery projects.  
The serotonin transporter (SERT) is widely reported to be expressed in caco-2 cells. 
Indeed caco-2 cells have been used to study the function of SERT(Iceta, Aramayona, 
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Mesonero, & Alcalde, 2008). Whether this transporter can mediate the transport of 
small molecule drugs is not clear. However, SERT has been reported to transport 
other molecules such as dopamine(Larsen et al., 2011). This suggests that SERT could 
indeed be responsible for transport of monoamines, as both serotonin and 
dopamine are monoamines. 
The breast cancer resistance protein (BCRP) is an efflux transporter known to 
transport a diverse range of molecules. The protein is reported to be expressed in 
caco-2 cells and indeed caco-2 cells are used in studies of the mechanistic function of 
BCRP. Gene knockout studies in caco-2 cells are also carried out which can help to 
identify and avoid potential substrates of efflux transporters.  
The multidrug resistance-associated protein 1 is part of a group of ABC proteins 
responsible for the efflux of chemically diverse group of molecules(Leslie, Deeley, & 
Cole, 2005). Evidence suggests that the MRP1 is expressed in caco-2 cells and 
therefore relevant to studies regarding carrier mediated transport in such cells 
(Prime-Chapman, 2004).  
3.2.3 Conclusions 
The caco-2 cell is reported to express a wide range of membrane transporters, a 
characteristic that gives the cell line resemblance to intestinal epithelial cells. 
However, an overview of the literature suggests that not many studies have tried to 
select a minimum expression threshold for caco-2 cells. The subsequent use of 
results of this study should therefore be interpreted with knowledge of potential 
limitations. The PIDGIN tool was therefore used in this study to predict substrates of 
the six membrane transporters listed above within the caco-2 dataset. Two of the 
membrane transporters listed are ion or metal transporters which may not be of 
direct relevance to permeability of small molecule drugs. The remaining transporters 
have been widely implicated in drug transport of a diverse range of molecules which 
suggests they are of relevance to membrane transport.  
The models for each protein in the target prediction tool, PIDGIN, were developed 
using active and inactive compounds from ChEMBL and PubChem respectively 
(Mervin et al., 2015).  Molecules that are active against membrane transporters, or 
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any protein for that matter, can be classified as substrates or inhibitors. The target 
prediction tool cannot distinguish between substrates and inhibitors of membrane 
transporters. This presents a potential limitation of using the target prediction tool 
to identify molecules that may undergo carrier mediated transport. These 
predictions were used in a binary fingerprint format as descriptors of carrier-
mediated transport for the purposes of developing predictive QSAR models of caco-2 
permeability. 
 
4. DEVELOPMENT OF CLASSIFICATION MODELS 
 
4.1 Caco-2 Permeability dataset 
The aim of this section is to give an outline of the datasets used to generate QSAR 
models. The classification criterion mentioned in the methods section (section 
5.2)has led to the selection of compounds with relevant permeability (Table 2). 
Table 2: Number of compounds in Caco-2 permeability dataset 
 
A
c
c
ording to the classification criteria mentioned in the methods section, 242 
compounds were unclassified in the A-B direction whereas 140 compounds were 
unclassified in the B-A direction. This is because the Papp values of these compounds 
lie between 1x10-6 and 5x10-6 cm/s. A plot of A-B and B-A permeability suggests, in 
general, that there is no correlation between A-B and B-A permeability (Figure 16). 
Direction Permeable count  
(Papp ≥ 1x10-6 cm/s) 
Impermeable count 
(Papp ≤ 1x10-6 cm/s) 
Unclassified Total 
A-B 486 241 242 969 
B-A 779 50 140 969 
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Figure 16: Plot of A-B vs B-A Papp values of caco-2 dataset 
This shows that for this set of compounds, there are factors influencing the 
permeability of some compounds in the B-A direction that may not be relevant in the 
A-B direction. The most likely reason why more compounds are permeable in the B-A 
direction is because they interact with and are transported by efflux transporters. 
However, this could also be the reason why molecules with high B-A permeability 
values may have low A-B values. 
A study of transport of epicatechin, a tea flavonoid with preventative properties for 
cancer, in caco-2 cells demonstrates how molecules can be more permeable in the B-
A direction compared with the A-B direction (Vaidyanathan & Walle, 2001). 
Epicatechin was found to be impermeable in the A-B direction but slightly permeable 
in the B-A direction (Papp = 0.67 x 10-6 cm/s). According to the criteria used in this 
study, this molecule would be classed as impermeable in both directions. 
Interestingly, in the presence of an inhibitor of multiple resistance protein 2 (MRP2), 
an efflux transporter, permeability in the A-B direction is clearly measured (Papp = 
0.31 x 10-6 cm/s). This suggests the impact of membrane transporters on both A-B 
and B-A permeability of molecules.  
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From the information available, the conclusion is that both passive diffusion and 
carrier mediated transport may be important for the permeability of molecules and 
in that case, QSAR models that incorporate descriptors of carrier mediated transport 
are expected to show better predictive performance to those developed from 
physicochemical and structural property descriptors alone. 
Table 3: Number of compounds in the efflux class 
High efflux Low efflux Unclassified Total  
135 367 467 969 
 
According to the classification criteria (section 5.2), there were 135 high efflux and 
367 low efflux compounds, making up a total of 502 compounds that have an efflux 
ratio that is either below 1 or above 10 (Table 3). This means 467 compounds had an 
efflux ratio above 1 and below 10 and thus could not be classified according to the 
criteria. These molecules were not used to generate predictive models of efflux class. 
It is often the case that molecules with high efflux ratios are substrates of efflux 
transporters. On the other hand, molecules with very low efflux ratios are substrates 
of uptake transporters but there were no molecules with very low efflux ratios (< 
0.1) in the caco-2 dataset. If the main mechanism by which a compound crosses a 
biological membrane is via passive diffusion, it is expected that the permeability of 
the compound in both directions will be roughly equal. With this in mind, it is 
expected that passive diffusion is the main permeation mechanism for low efflux 
compounds in this dataset. We also hypothesize that high efflux molecules are 
substrates of efflux transporters. Because physicochemical descriptors have a 
tendency to describe the likelihood of a molecule undergoing passive diffusion, it is 
expected that reliable descriptors of carrier-mediated transport will improve the 
performance of predictions of caco-2 efflux classification carrier-mediated processes 
are explicitly taken into account.  
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Table 4: Number of compounds in each of the efflux classes when compounds are 
clustered 
High efflux Low efflux Total  
109 252 361 
 
Clustering the compounds and taking the centroid molecule results in a total of 361 
cluster centroids, 109 of which are high efflux and 252 are low efflux centroids (Table 
4).  
 
4.2 A-B Permeability 
4.2.1 Results and Discussion  
From the original pool of descriptors, backward feature elimination was used to 
select the best combination of descriptors for Logistic regression. 31 descriptors 
were selected including lipophilicity (logD at pH =7.4), prototation (pKa) and MACCS 
keys descriptors. 
Table 5: Performance of Logistic regression classifier in A-B permeability 
classification  
Descriptors Average  
Accuracy 
Accuracy 
(sd) 
P-value Average 
Kappa 
Kappa 
(sd) 
P-value 
Standard 
descriptors 0.91 0.01 - 0.79 0.01 - 
 
The backward feature selection process did not select any of the active transport 
descriptors (NMTS or PIDGIN). Given that 91% of compounds were classified 
correctly, the combination of backward feature selection with logistic regression can 
be considered an effective method of selecting from a pool of descriptors, the best 
combination for predicting whether compounds are permeable or non-permeable in 
the A-B direction.  
The Cohen’s Kappa value of 0.79 suggests relatively good agreement between actual 
class and predicted class. The difference in classification accuracy and Cohen’s Kappa 
is most likely due to the slight imbalance in the A-B permeability dataset. If the high 
classification accuracy is indeed due to the performance of the model, the Cohen’s 
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kappa value could possibly be increased by balancing the datasets in terms of 
number of permeable and non-permeable compounds.  
Compared with findings from similar studies such as by Pham The et al. (Pham The et 
al., 2011), this classification performance is good. However, direct comparisons 
cannot be made due to the differences in methodologies. For example, the datasets 
used in other studies contain data obtained from different sources and thus likely to 
contain structurally diverse sets of compounds. The learning algorithms used are also 
different; one advantage of such models is that they may be applicable to a wider 
range of molecules. However, the datasets used in such studies are often small 
(largest one from Pham The et al. (Pham The et al., 2011) contains 567 compounds) 
compared to the dataset used in this study (969 compounds).  
The fact that none of the active transport descriptors were included by backward 
elimination suggests that NMTS and PIDGIN descriptors do not provide new 
information to the models. As a result, it was not possible to compare active 
transport descriptor based models to standard descriptor based models using the 
logistic regression classifier. However, it is worth bearing in mind that MACCS keys 
are included in the set of ‘standard’ descriptors. Some of the substructures encoded 
by MACCS keys are relevant to membrane transport. Because of the ‘promiscuous’ 
nature of membrane transporters (Kell et al., 2013), it is possible that these 
substructures do in fact encode the likelihood of molecules undergoing active 
transport. Descriptors such as the polar surface area (PSA) of the molecule are also 
directly related to some of the substructures such as number of oxygens in carbonyl 
groups. The lipophilicity of the molecule is also closely related to these 
substructures. After all, it is the combination of such structures in a molecule that 
gives rise to molecular properties such as lipophilicity and polar surface area. 
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Figure 17: Distribution of NMTS values for Permeable and Impermeable compounds 
in the A-B direction 
There was no clear distinction between the nearest metabolite Tanimoto similarity 
(NMTS) values of permeable and impermeable compounds in the A-B direction 
(Figure 17). This suggests a lack of a relationship between permeability in the A-B 
direction and similarity to endogenous metabolites. Interestingly, a very recent 
article published by the same group who suggested metabolite likeness as a measure 
of the likelihood of molecules undergoing carrier mediated transport shows results 
that agree with this study. A weak positive correlation of 0.156 (R2) suggests no 
relationship between caco-2 permeability and metabolite likeness for the dataset 
used in that study (O’Hagan & Kell, 2015). It is likely that this is the reason why NMTS 
does not improve the performance of models and thus was not selected by 
backward feature selection.  
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Table 6: Important descriptors that contribute significantly to the overall accuracy of 
logistic regression in caco-2 Apical to Basolateral classification. The non-randomised 
Classification Accuracy is 91% ± 1% (0.91 ± 0.01). There were 31 descriptors to begin 
with. Bonferroni’s critical value was 0.05/31 = 1.60E-03 (0.0016). Only descriptors 
with p-values below this value are shown in this table.  
Randomised descriptor description Δ mean 
accuracy (%) 
P-value 
logD at pH=7.4 LogD at pH of 7.4 -3.28 9.34E-21 
#XN where coord. # of X>=3 Nitrogen bonded to 
atom with at least 3 
bonds 
-2.74 2.43E-19 
#ring atoms Number of ring atoms -1.50 9.30E-11 
#S in double/charge separated 
bonds 
Sulphur in 
double/charge 
separated bonds 
-1.26 6.29E-09 
#OH groups Number of OH groups -1.19 1.41E-08 
#halogens Number of halogens -0.93 8.25E-07 
(key(160)-1 if key(160)>1; else 0) 
Key160 = #CH3 groups 
Number of methyl 
groups subtract 1 
-1.12 9.05E-07 
#O in C=O Number of Oxygens in 
C=O groups 
-0.97 1.57E-06 
#N Number of Nitrogens -0.99 2.41E-06 
#N in double bonds Number of double 
bonded Nitrogens 
-0.88 1.01E-05 
Strongest BASIC pKa 2 pKa of the second most 
basic group 
-0.80 1.55E-05 
#N non-ring bonded to a ring Non ring Nitrogens 
bonded to a ring atom 
-0.68 9.91E-05 
#N separated by 4 bonds Nitrogens separated by 
4 bonds 
-0.69 1.42E-04 
Key(164)-1 if key(164)>1; else 0 
Key164 = # oxygens 
Number of Oxygens 
subtract 1 
-0.62 2.19E-04 
#heteroatoms in 5 ring Number of heteroatoms 
in 5 membered ring 
-0.68 4.98E-04 
  
Out of the 31 descriptors selected by backward feature selection (Appendix Table A. 
2), only 16 reduced the accuracy significantly when randomised. An Independent 
samples t-test was carried out to compare the mean when each descriptor in the 
dataset is randomised to the mean when none of the descriptors are randomised. 
Bonferroni’s method was applied to account for the multiple comparisons problem. 
Only those descriptors with a p-value less than the Bonferroni’s critical value 
(calculated as 0.05/n where n is the number of comparisons considered) are shown. 
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The negative value for the t-statistic shows that the accuracy when each of these 
descriptors is randomised is less than that of the non-randomised accuracy. The 
magnitude of the t-value corresponds to the effect that each descriptor has on the 
overall accuracy when randomised.  
Randomisation of logD resulted in the biggest reduction in accuracy (-3.28%). LogD 
represents the octanol-water distribution of ionisable compounds and is dependent 
on the pH of the solution(Kah & Brown, 2008). This suggests that lipophilicity is an 
important property for determining the permeability of compounds. Hydrogen 
bonding groups are widely reported to influence the membrane permeability of 
molecules(Refsgaard et al., 2005). The inclusion of nitrogen and oxygen containing 
substructures of the MACCS keys descriptor set in the list of important descriptors 
indicates a possible strong contribution of polarity and hydrogen bonding capacity to 
caco-2 permeability in the A-B direction.  
That NMTS and PIDGIN descriptors are not included in the list of important 
descriptors does not disprove of the idea that carrier mediated transport descriptors 
can contribute to the overall accuracy. It is more likely that the information encoded 
by either nearest metabolite similarity or PIDGIN descriptors is already contained in 
the list of standard descriptors.  
MACCS keys substructure counts were included in the list of standard descriptors. 
Some of these substructures (e.g. number of oxygens in carbonyl groups) are of 
relevance to protein binding and therefore relevant to membrane transporter 
binding. The fact that most of the important descriptors are MACCS keys 
substructures rather than physicochemical descriptors suggests that protein binding 
could be an important factor in determining membrane permeability. MACCS keys 
are often widely used to predict the bioactivity of molecules against specific targets 
which adds value to the idea that MACCS keys substructures may actually be 
encoding the likelihood of molecules undergoing active transport (Cheng et al., 
2012).  
One study has made use of MACCS structural keys as descriptors for development of 
QSAR models of permeability (Gozalbes, Jacewicz, Annand, Tsaioun, & Pineda-
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Lucena, 2011). The model was developed using 14 descriptors, 9 of which are MACCS 
keys (Figure 18). The model shows good performance with an R2 value of 0.77. 
Interestingly, some of the MACCS keys selected for model development have also 
been found to be important in the descriptor randomization process carried out in 
this study (Table 6). 
 
Figure 18: Descriptors and coefficients for the best QSAR model of caco-2 
permeability from Gonzalbes at al. (2014)  
The number of heteroatoms in four-membered rings has a coefficient of -1.25 
suggesting a negative effect on permeability. In this study, it is the number of 
heteroatoms in five-membered ring that is important in determining whether a 
molecule is permeable or impermeable in the A-B direction. The number of hydroxyl 
(OH) groups is shown to have a negative effect on permeability. In this study, 
multiple models were generated making it impossible to analyse individual 
coefficients from individual models. The randomization process was one way to 
measure the importance of individual descriptors. 
Substructure pattern fingerprints have been used to generate predictive 
classification QSAR models of human intestinal absorption and blood brain barrier 
permeability(Shen, Cheng, Xu, Li, & Tang, 2010). The models generated showed 94% 
accuracy in predicting human intestinal absorption and 69.5% accuracy for blood 
brain barrier permeability. It is also reported that certain substructures correlate 
very well with membrane permeability. 
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One study applied the molecular interaction field technique for predicting inhibitors 
of the permeability glycoprotein (P-gp) (Broccatelli et al., 2011). The study found that 
conformational as well as hydrophobic and hydrogen bond acceptor characteristics 
were important for predicting inhibitors of P-gp. This suggests a limitation in the 
findings of this study. The structural keys found to be important for predicting 
permeability may be important for both inhibitors and substrates of membrane 
transporters.  
Certain substructures have been reported to be more prevalent in bioactive 
compounds and the presence of such structures can significantly increase bioactivity 
(Klekota & Roth, 2008). Given that a number of MACCS keys are considered 
important for permeability, the idea of prevalent substructures could also be 
relevant to membrane permeability. One would expect the prevalence of certain 
substructures to be more relevant to carrier mediated transport. However, it is the 
presence or absence of such substructures that give rise to a molecule’s 
physicochemical properties. Such properties are therefore important for both 
passive diffusion carrier mediated transport processes. This highlights one of the 
difficulties in separating passive diffusion and carrier mediated transport process 
descriptors for the purpose of developing QSAR models of permeability. 
Models for predicting the permeability of a group of flavonoid molecules in caco-2 
cells based on both 2D and 3D descriptors show that electronic, topological, 
hydrogen bonding and hydrophobic properties are important determinants of 
permeability (Gonzales et al., 2015). This is in agreement with the results obtained in 
the descriptor randomization process which suggest the importance of lipophilicity 
(logD at pH=7.4), protonation (Strongest Basic pKa 2) and certain MACCS structural 
keys. 
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Table 7: Performance of Naïve Bayes learner in Apical to Basolateral classification 
Descriptors Average  
Accuracy 
Accuracy 
(sd) 
P-value 
(Accuracy) 
Average 
Kappa 
Kappa 
(sd) 
P-value 
(Kappa) 
Standard 
0.83 0.01 - 0.60 0.01 - 
Standard and 
NMTS 0.83 0.01 0.47 0.60  0.01 0.38 
Standard and 
PIDGIN 0.83 0.00 0.46 0.60 0.01 0.47 
 
The Naïve Bayes classifier achieved a mean accuracy of 0.83 (± 0.01) and a mean 
Kappa of 0.60 (± 0.01) when modelled with standard descriptors alone (Table 7). A 
mean accuracy of 0.83 ± 0.01 and mean Kappa of 0.60 ± 0.01 was achieved with a 
combination of standard descriptors and nearest metabolite similarity (NMTS). The 
combination of standard descriptors and PIDGIN descriptors resulted in a mean 
accuracy of 0.83 ± 0.01 and a mean Kappa of 0.60 ± 0.01. The p-values obtained are 
greater than the threshold of 0.05 which suggests that NMTS and PIDGIN descriptors 
did not improve the performance of the Naïve Bayes classifier in predicting A-B 
permeability.  
The Logistic regression classifier (Table 5) generally performs better than the Naïve 
Bayes classifier (Table 7). This is despite the fact that more descriptors were used in 
generating the Naïve Bayes models. It is often mentioned in literature that the more 
descriptors a classifier is given the better its performance (Dearden, Cronin, & Kaiser, 
2009). It could be the case that backward feature selection is a more effective 
method of selecting important descriptors compared with simple variance and 
correlation filters. However, a review of the literature shows no clear evidence 
suggesting certain feature selection methods are better than others (Dash & Liu, 
1997; Maldonado & Weber, 2009; Yu & Liu, 2004).  
It is widely reported that the more descriptors used, the more likely it is that models 
generated will be over-fitted to the molecules used to train the model (Dearden et 
al., 2009). Logistic regression models in this case are therefore likely to be better at 
predicting novel molecules compared with the Naïve Bayes classifier. 
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Table 8: Important descriptors that contribute significantly to Apical to Basolateral 
permeability classification Accuracy with Naïve Bayes classifier. The non-randomised 
accuracy is 83% ± 0.45 (0.83 ± 0.0045). The Bonferroni critical value was 0.05/144 = 
3.55E-04.  
Randomised descriptor Δ mean accuracy (%) P-value 
Polar surface area -0.74 7.60E-05 
 
Out of 142 descriptors, randomisation of polar surface area alone causes a 
statistically significant reduction in the classification accuracy of the Naïve Bayes 
classifier (Table 8). While the reduction in accuracy is not large (-0.74), the fact that a 
single variable in such a high dimensional dataset can reduce the accuracy at all is 
interesting. The polar surface area of a molecule represents the surface area of 
oxygen and nitrogen atoms within the molecule. High polar surface area has been 
reported to be unfavourable to the caco-2 permeability of molecules(T. J. Hou et al., 
2004). Although not selected as important with the Logistic regression classifier, 
some aspects of polar surface area may be represented by MACCS structural keys 
descriptors that are selected. Examples of such structural keys include the number of 
oxygen and nitrogen atoms. The fact that neither metabolite similarity nor PIDGIN 
predictions cause reduction in accuracy when randomised suggests that they do not 
add information to the standard descriptors. 
Table 9: Performance of Random Forest classifier in Apical to Basolateral (A-B) 
classification. 
Descriptors Average  
Accuracy 
Accuracy 
(sd) 
P-value 
(Accuracy) 
Average 
Kappa 
Kappa 
(sd) 
P-value 
(Kappa) 
Standard 
0.88 0.01 - 0.72 0.02 - 
Standard 
and NMTS 0.88 0.01 0.36 0.72 0.02 0.40 
Standard 
and PIDGIN 0.88 0.01 0.55 0.72 0.03 0.58 
 
Similarly to the Naïve Bayes classifier, the results of the Random Forest classifier 
suggest no improvement when metabolite similarity and PIDGIN predictions are 
added (Table 9). The same set of descriptors were used for both Random Forest and 
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Naïve Bayes classifiers. The Random Forest classifier however shows improved 
classification accuracy and Kappa compared with Naïve Bayes classifier (Table 7). 
This is probably due to the nature of both algorithms. One of the main limitations of 
the Naïve Bayes classifier is that it uses all descriptors and makes the ‘naïve’ 
assumption that all descriptors are independent of one another(Wang et al., 2012). 
The WEKA implementation of the Random Forest classifier selects randomly 8 
descriptors to generate a tree(Hall et al., 2009). This most likely reduces the 
likelihood of overfitting the model and thus increases the predictive performance. 
One study, concerned with predictions of ADME properties, found that the Random 
Forest classifier is at least as good and in most cases superior to the Naïve Bayes 
classifier (B. Chen, Sheridan, Hornak, & Voigt, 2012). These findings are in agreement 
with the results obtained in this study.  
None of the descriptors, when randomized, caused significant reduction in the 
overall A-B permeability classification accuracy.  This is most likely because of the 
bootstrapping method applied in the Random Forest classifier. Important descriptors 
for model performance may vary for each bootstrap, hence, randomisation of each 
descriptor in turn may not cause a significant reduction in accuracy. Random Forest 
classifiers are widely reported to perform well with high dimensional data because of 
their inherent ability to ignore irrelevant descriptors (Svetnik et al., 2003).  In that 
case, it may be possible that some descriptors in the dataset were related to each 
other. As a result, the randomisation of such descriptors is unlikely to reduce the 
predictive accuracy of the Random Forest classifier. 
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Figure 19: Performance of the different classifiers in the A-B permeability 
classification 
Figure 19 shows that Logistic regression classification resulted in the highest 
classification accuracy and Cohen’s Kappa values while the Naïve Bayes classifier was 
the worst. All the methods appear to show good classification performance of at 
least 80%. The results of this study are in general similar to those obtained in similar 
studies(Pham The et al., 2011; Refsgaard et al., 2005). 
4.2.2 Conclusions   
In drug discovery, the permeability of molecules is an important property for which 
in silico predictive models are sought. Indeed many studies have attempted to 
predict human intestinal permeability through data obtained from in-vitro models. 
However, there is no attempt in literature to model passive diffusion and carrier 
mediated transport processes separately. The main aim of this study was to 
investigate whether the inclusion of novel descriptors of carrier mediated transport 
improves the predictive performance of models. It is evident that the different 
methods applied result in models that perform differently in terms of overall 
classification accuracy and Cohen’s Kappa. Statistically, novel descriptors did not 
improve the predictive accuracy of models of A-B permeability. The descriptor 
randomization process however showed the importance of certain substructures in 
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determining permeability. Such substructures contribute to the physicochemical 
properties of the molecule, suggesting contribution to passive diffusion, but may 
also be important in binding to membrane transporters. The combination of 
backward feature selection with Logistic regression classification yielded the best 
performance in terms of classification accuracy and Cohen’s Kappa. This suggests 
that this method can be of use in predicting the permeability of molecules in the 
absorptive direction. The Random Forest classifier shows higher performance 
compared with the Naïve Bayes classifiers despite using the same set of descriptors 
for model development.  
 
4.3 B-A Permeability 
4.3.1 Results and Discussion 
The permeability of a drug molecule in the B-A direction can have an impact on its 
efficacy. It is therefore desirable to predict whether or not molecules are permeable 
in the B-A direction. This section presents the performance of QSAR models of B-A 
permeability. Furthermore, models generated from ‘standard’ physicochemical and 
structural property descriptors are compared with models generated from a 
combination of physicochemical property and carrier-mediated transport 
descriptors. 
Table 10: Performance of Logistic regression classifier in Basolateral to Apical (B-A) 
permeability 
Descriptors Average  
Accuracy 
Accuracy
(sd) 
P-value Average 
Kappa 
Kappa 
(sd) 
P-value 
Standard 
0.93 0.00 - 0.26 0.04 - 
 
The backward feature selection was used for selecting descriptors for the Logistic 
regression classification of B-A permeability. The Logistic regression classifier shows 
good performance in terms of overall classification accuracy (93%) but poor 
performance (0.26) in terms of the Cohen’s Kappa value (Table 10). This is most likely 
due to the imbalance in the dataset used to develop the models, which means the 
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probability of random agreement between predicted and actual class is high. It is 
reported that one of the problems associated with learning from imbalanced 
datasets is that the models often perform poorly on the minority class(Jeni, Cohn, De 
La Torre, & others, 2013).  
The backward feature selection method did not select any of the novel descriptors of 
carrier mediated transport (NMTS and PIDGIN predictions) as important. As a result 
we could not compare the performance of models generated from inclusion of active 
transport descriptors with models generated from standard physicochemical 
property descriptors.  
Table 11: Important descriptors that contribute significantly to B to A classification 
with Logistic Regression classifier. The non-randomised accuracy was 94% ± 0.37 
(0.94 ± 0.0037).  
Randomised 
descriptor 
Description Δ mean 
accuracy (%) 
P-value  
# O in C=O Number of Oxygens in C=O -0.75 4.34E-08 
# 5-membered rings Number of 5 membered rings -0.52 1.19E-05 
# ring atoms Number of ring atoms -0.56 8.49E-05 
# O in rings Number of Oxygen atoms in 
rings 
-0.41 2.38E-04 
# CH2s separated 
by 3 bonds 
Number of CH2 groups 
separated by 3 bonds 
-0.48 3.47E-04 
# N Number of Nitrogen atoms -0.46 4.77E-04 
 
From the descriptors selected by backward feature selection (Appendix Table A. 3), 
six MACCS structural keys appear to be significant contributors in prediction of B-A 
apparent permeability class according to descriptor randomization (Table 11). The 
inclusion of oxygen and nitrogen containing substructures is in agreement with the 
idea that B-permeability is highly driven by efflux transporters (Dolghih & Jacobson, 
2013b). This is most likely due to formation of hydrogen bonds and hydrophobic 
interactions with efflux transporters. Indeed many studies concerned with predicting 
substrates of efflux transporters make use of pharmacophore models, most of which 
find hydrogen bond donors and acceptors as well as hydrophobic properties as 
important for interactions(Chang, Ekins, Bahadduri, & Swaan, 2006; Garrigues et al., 
2002). 
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In comparison with the list of descriptors found to be important in the A-B direction, 
this list contains much fewer descriptors. This may suggest that not as many 
descriptors are relevant to the permeability of molecules in the B-A direction, a likely 
result of the ‘promiscuous’ nature of efflux transporters (Kell et al., 2013; Wong, Ma, 
Rothnie, Biggin, & Kerr, 2014). The biggest reduction in accuracy is caused by the 
randomization of number of carbonyl groups (#O in C=O). This adds more value to 
the idea that hydrogen bonding is an important contributor to the permeability of 
compounds in the B-A. In future studies, it would be ideal to have the coefficients to 
determine whether hydrogen bonding has a negative or positive effect on 
permeability. It would be also be beneficial to investigate the prevalence of such 
structures in permeable and non-permeable molecules.  
Table 12: Performance of Naïve Bayes classifier in B-A permeability classification  
Descriptors Average  
Accuracy 
Accuracy 
(sd) 
P-value Average 
Kappa 
Kappa 
(sd) 
P-value 
Standard 0.82 0.01 - 0.15 0.02 - 
Standard and 
NMTS 0.82 0.01 0.06 0.17 0.02 0.04 
Standard and 
PIDGIN 0.82 0.01 0.44 0.16 0.02 0.43 
 
The results of the Naïve Bayes classifier also suggest that the novel descriptors of 
carrier mediated transport do not improve the model performance (Table 12). There 
is a statistically significant improvement in Kappa when metabolite similarity is 
combined with the set of standard descriptors (p = 0.04). However, the difference in 
the Kappa values cannot be considered large in practical terms. In terms of 
classification accuracy, the result of including metabolite similarity is approaching 
the level of significance (p = 0.06).  
None of the descriptors reduce the predictive accuracy of the Naïve Bayes classifier 
significantly when randomised. There are two possible reasons for this. Firstly, with 
144 descriptors, it is unlikely that randomisation of a single descriptor will have 
much of an impact on the model performance. Secondly, the Naïve Bayes classifier 
makes a basic assumption that all descriptors are independent of one another.  
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Table 13: Performance of Random Forest classifier in B-A permeability classification 
Descriptors Average  
Accuracy 
Accuracy 
(sd) 
P-value Average 
Kappa 
Kappa 
(sd) 
P-value 
Standard 
0.94 0.00 - 0.19 0.06 - 
Standard and 
NMTS 0.94 0.00 0.64 0.19 0.05 0.73 
Standard and 
PIDGIN 0.94 0.00 0.90 0.19 0.05 0.75 
 
There were no statistically significant results in B-A permeability classification with 
the Random Forest classifier which suggests novel descriptors of carrier mediated 
transport failed to improve the performance of the model (Table 13).  However, for 
Naïve Bayes and Random Forest classifiers, over 100 standard descriptors are used in 
model generation. It is highly unlikely that a single descriptor, nearest metabolite 
similarity, will make an impact when included in such a pool of descriptors.  
When randomised, no individual descriptor reduces the classification accuracy of the 
Random Forest classifier significantly. The reasons for this are most likely similar to 
those mentioned above for the Naïve Bayes classifier.  
 
Figure 20: B-A permeability classification of all models 
The Random Forest and Logistic regression classifier appear to be roughly matched 
in terms of classification accuracy (Figure 20). The Naïve Bayes classifier shows the 
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lowest classification accuracy and Cohen’s Kappa values. This is an interesting finding 
considering the Random Forest and Naïve Bayes classifiers were generated using the 
same set of descriptors. This is most likely an indication that the Naïve Bayes 
classifier is more prone to overfitting than the Random Forest classifier. As 
mentioned previously, the Random Forest generates a tree from 8 randomly 
selected descriptors which reduces the chance of overfitting the model.  
Due to the unbalanced B-A dataset used, low Cohen’s Kappa values were obtained. 
To circumvent this, the datasets were balanced and the Naïve Bayes and Random 
Forest classification models were developed (Table 14 and Table 15).  
The above mentioned classifiers were developed using a highly imbalanced dataset. 
Over 90% of the molecules belonged to the permeable set of compounds. To address 
this issue, the dataset was balanced and the Naïve Bayes and Random Forest 
classification models were developed. Because of the long running time of backward 
feature selection, the Logistic regression classifier was not used in this case. 
Balancing of datasets was carried out by splitting the permeable compounds into 14 
sets, each containing 55 permeable molecules to roughly match the non-permeable 
class containing 50 molecules.  
Table 14: Performance of the Naïve Bayes algorithm when datasets are balanced 
Descriptors Average  
Accuracy 
Accuracy 
(sd) 
P-value Average 
Kappa 
Kappa 
(sd) 
P-value 
Standard 0.83 0.09 - 0.66 0.17 - 
Standard and 
NMTS 0.84 0.08 0.78 0.63 0.15 0.78 
Standard and 
PIDGIN 0.82 0.09 0.48 0.67 0.17 0.48 
 
The performance of the Naïve Bayes classifier, in terms of overall classification 
accuracy, does not change significantly when datasets are balanced (Table 14). For 
example, with standard descriptors, the average classification accuracy of an 
unbalanced dataset is 82% (Table 12) whereas the classification accuracy on a 
balanced dataset with the same descriptors is 83% (Table 14). One would expect a 
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reduction in the performance of the model on a balanced dataset, however, the 
same number of descriptors were used for the imbalanced and balanced datasets.  
Table 15: Performance of the Random Forest classifier when datasets are balanced 
and cluster centroids used in model generation 
Descriptors Average  
Accuracy 
SD 
Accuracy 
P-value Average 
Kappa 
SD Kappa P-value 
Standard 0.82 0.10 - 0.64 0.19 - 
Standard and 
NMTS 0.82 0.10 0.86 0.65 0.19 0.86 
Standard and 
PIDGIN 0.83 0.09 0.75 0.65 0.18 0.75 
 
The performance of Random Forest classifiers, contrary to the Naïve Bayes classifier, 
appears to be influenced by the imbalance in the dataset (Table 15). For example, 
the highest B-A permeability classification accuracy with an unbalanced dataset for 
the Random Forest classifier is 94% (Table 13). When the model is trained on 
datasets with balanced classes, the highest classification accuracy achieved is 83% 
(Table 15), when standard descriptors are combined with PIDGIN predictions. This 
finding is in agreement with studies that have made use of the Random Forest 
classifier and it is evidence of a possible disadvantage of the Random Forest classifier 
compared with the Naïve Bayes classifier. In this case, the result does not appear to 
be influenced by the class imbalance in the dataset.  
4.3.2 Conclusions  
The inclusion of novel descriptors of carrier mediated transport (NMTS and PIDGIN 
predictions) failed to improve the performance of models in B-A permeability 
classification. This is evidenced by the lack of p-values below the significance 
threshold (p<0.05). However, the descriptor randomisation technique employed in 
this study showed that some structural descriptors, e.g. number of carbonyl groups 
and the presence of rings, are important features that may determine the 
permeability of molecules in the B-A direction. While such substructures have an 
influence on the lipophilicity, and consequently likelihood of permeability via passive 
diffusion, one can argue that such substructures are also relevant to protein binding. 
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As a result, one can argue that the capability of molecules undergoing carrier-
mediated transport is encoded in those substructures.  
To date, not many QSAR models of B-A permeability have been published. The most 
likely reason is that the interest of drug discovery projects lies in the prediction of 
intestinal absorption of molecules, and as such, many studies have focused on 
predicting permeability in the absorptive direction (Deli et al., 2005; Dolghih & 
Jacobson, 2013a; Guangli & Yiyu, 2006). While the importance of predicting A-B 
permeability is acknowledged, the results of this study suggest that predictions of B-
A permeability are possible, and as such, should be pursued. Such models may be 
useful in predicting, and thus help to avoid, molecules that are highly permeable in 
the B-A direction. Because not many studies have pursued B-A permeability 
predictions, it was not possible to compare results obtained in this study with other 
studies. 
 
4.4 Efflux ratio classification 
4.4.1 Results and Discussion  
The ratio of B-A and A-B permeability (efflux ratio) is widely used to determine the 
extent to which permeability of molecules is affected by efflux transporters.  It is 
therefore important to be able to predict the likelihood of molecules undergoing 
efflux. The aim of this section is to present the results of the predictions of 
classification methods.  
Table 16: Performance of Logistic regression learner in Efflux ratio classification 
Descriptors Average  
Accuracy 
Accuracy 
(sd) 
P-value Average 
Kappa 
Kappa 
(sd) 
P-value 
Standard 
0.88 0.01 - 0.71 0.01 - 
 
The backward feature selection method was used to select descriptors for efflux 
ratio class predictions for the Logistic regression classifier (Table 16). None of the 
novel descriptors of carrier mediated transport were selected which suggests that 
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they do not add extra information to that already contained in the physicochemical 
and structural property descriptors. On average, 88% of the molecules were 
correctly classified. The Kappa value of 0.71 suggests good agreement between 
actual and predicted class taking random agreement into consideration. This 
suggests that the combination of backward feature selection and Logistic regression 
classification can be useful in predicting the efflux ratio of molecules. Such 
predictions could be useful for identifying and avoiding potential substrates of efflux 
transporters. 
In order to identify descriptors that contribute the most to model performance, each 
descriptor was randomized and the resulting accuracy compared to that of the non-
randomised model using the independent samples t-test. 
Table 17: Important descriptors that contribute significantly to efflux classification 
with Logistic regression. The non-randomised accuracy is 0.88 ± 0.01. The number of 
descriptors selected is 9. The Bonferroni critical value applied is 5.56E-03 (0.05/9)  
Randomised descriptor Description Δ mean 
Accuracy (%) 
P-value 
#N Number of Nitrogen 
atoms 
-3.30 2.86E-21 
#non-C with coordination 
number >=3 
Number of non-C atoms 
bonded to at least 3 
atoms 
-2.85 1.04E-19 
#O in C=O Number of oxygen in C=O 
groups 
-2.59 3.43E-19 
#N bonded to >= 3 C Number of N bonded to 3 
or more carbons 
-2.43 8.39E-18 
#S in double/charge 
separated bonds 
Sulphur in double/charge 
separated bonds 
-2.42 1.57E-16 
#CH3 groups Methyl groups -1.98 9.53E-14 
#atoms separated by 
(!:):(!:) 
Four atoms connected by 
non-aromatic bonds 
-1.53 5.30E-12 
Strongest ACIDIC pKa 1 pKa of the strongest acidic 
group 
-1.29 9.25E-11 
#heteroatoms in 5 ring heteroatoms in 5 
membered rings 
-0.63 1.66E-04 
 
Table 17 shows the descriptors that, when randomised, cause a significant reduction 
in the predictive accuracy of efflux classification with the logistic regression classifier 
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(refer to Appendix Table A. 4 for full list of descriptors).  The inclusion of nitrogen 
and oxygen containing substructures suggests the importance of polarity and 
possibly hydrogen bonding on efflux ratio. Hydrogen bond acceptor groups of 
substrates were found to be particularly important for the interaction with P-gp 
(efflux transporter) (Desai, Raub, & Blanco, 2012). This is in agreement with this 
study which shows that the number of carbonyl groups and the number of nitrogen 
atoms are important determinants of efflux ratio.  
The addition of methyl groups is reported to reduce the efflux ratio of prednisolone 
and other glucocorticoids (Yates et al., 2003). In this study, the abundance of methyl 
groups is also shown to have an impact on efflux ratio. For some of the descriptors, it 
is not clear why they are considered important in determining the efflux ratio e.g. 
the number of Sulphur atoms in double/charge separated bonds. The acidity of a 
molecule is often reported as an important property for membrane permeability, 
hence, it is no surprise it is included in the list of important descriptors.  
Table 18: Performance of Naïve Bayes learner in Efflux ratio classification 
Descriptors Average  
Accuracy 
Accuracy 
(sd) 
P-value 
(Accuracy) 
Average 
Kappa 
Kappa 
(sd) 
P-value 
(Kappa) 
Standard 
0.86 0.01 - 0.67 0.02 - 
Standard 
and NMTS 0.87 0.01 0.02 0.68 0.02 0.03 
Standard 
and PIDGIN 0.87 0.02 0.001 0.68 0.01 0.001 
 
Table 18 shows that with the Naïve Bayes classifier, statistically significant 
improvements in both accuracy and Cohen’s Kappa are seen with the inclusion of 
novel descriptors of carrier mediated transporters. However, statistical significance 
does not necessarily correspond to practical significance (Kenny & Montanari, 2013). 
The differences observed in this study, while statistically significant, do not appear 
practically meaningful. However, the general performance of the Naïve Bayes 
classifier is good. The lack of QSAR studies aiming to predict efflux ratio means that 
these results cannot be compared with results in literature, and provides further 
evidence of the novelty of this work.  
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Table 19: Important descriptors that contribute significantly to efflux classification 
with Naïve Bayes algorithm; Bonferroni’s critical value = 3.55E-04; Non-randomised 
Accuracy = 0.87 ± 0.008;  
Randomised descriptor Δ mean Accuracy (%) p-value 
Polar surface area -2.33 6.12E-07 
 
Table 19 shows that only one descriptor, Polar Surface area (PSA), reduces the 
predictive accuracy of the Naïve Bayes classification model of efflux ratio 
significantly. PSA represents the surface area of the molecule that is likely to interact 
with polar environments and is widely used in medicinal chemistry to optimise a 
molecule’s ability to permeate cell membranes. One would expect high PSA to 
reduce the likelihood of a molecule to undergo passive diffusion. For molecules that 
permeate predominantly via passive diffusion, one would expect PSA to have an 
equal effect in both A-B and B-A permeability and thus no effect on the efflux ratio. 
However, for molecules that permeate via both passive diffusion and carrier 
mediated transport, one would expect PSA to have an effect. Judging by the number 
of molecules permeable in the B-A direction but not permeable in the A-B direction 
(therefore likely to belong to the high efflux class), it is therefore no surprise that 
PSA is considered an important determinant for efflux ratio of molecules in the caco-
2 dataset used in this study. 
Table 20: Performance of Random Forest learner in Efflux ratio classification 
Descriptors Average  
Accuracy 
Accuracy 
(sd) 
P-value 
(Accuracy) 
Average 
Kappa 
Kappa 
(sd) 
P-value 
(Kappa) 
Standard 
0.90 0.01 - 0.75 0.02 - 
Standard 
and NMTS 0.89 0.01 0.14 0.74 0.02 0.12 
Standard 
and PIDGIN 0.89 0.01 0.04 0.74 0.02 0.03 
 
Surprisingly, the inclusion of PIDGIN predictions appears to reduce the classification 
accuracy (p = 0.04) and Cohen’s Kappa values (p = 0.03) for the Random Forest 
classifier (Table 20). Inclusion of metabolite similarity does not appear to have an 
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impact on the performance of the model in terms of both accuracy and Cohen’s 
Kappa. However the reason we get a small p-value in this case is most likely due to 
very small values of standard deviation. This reduction is therefore not practically 
meaningful. Another reason we may get a significant reduction with Random Forests 
is because the classifier selects 8 descriptors for each tree. It may actually be the 
case that none of the PIDGIN descriptors are selected. It is difficult to analyse which 
descriptors are being selected for the Random Forest method because over 100 
models (20 iterations multiply by 5-fold cross validations) are being generated. 
None of the descriptors cause significant reduction in the performance of the 
Random Forest classifier when randomised. The reasons for this are most likely 
similar to those mentioned in earlier sections, relating to the total number of 
descriptors in the pool and how it is unlikely to observe significant changes in model 
performance when a single descriptor is randomized. 
 
Figure 21: Performance of efflux ratio classifiers 
For efflux classification with the original dataset, the Random Forest classifier shows 
the best performance in terms of accuracy and Kappa compared with other 
classification methods (Figure 21). All the methods applied result in classification 
accuracy of at least 85%, with the Random Forest classifier approaching a 90% 
correct classification rate. The lack of QSAR studies aiming to predict caco-2 efflux 
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ratio means that the results of this study cannot be compared to that of other 
studies as there is a lack of publicly available data. 
Cluster centroid based classification models of efflux ratio 
When molecule cluster centroids (refer to methods section 5.2) are used in model 
development, one expects the accuracy and kappa values of subsequent models to 
reduce significantly. This process eliminates the possibility of having an 
overrepresented chemical series in the dataset which can result in model overfitting. 
Such models are expected to give a more accurate picture of the likely performance 
of the models on external datasets.  
Table 21: Performance of Logistic Regression learner in Efflux ratio classification 
when compounds are clustered and cluster centroid used in model development 
Descriptors Average  
Accuracy 
Accuracy 
(sd) 
P-value 
(Accuracy) 
Average 
Kappa 
Kappa 
(sd) 
P-value 
(Kappa) 
Standard 
0.81 0.01 - 0.51 0.01 - 
Standard 
and PIDGIN 0.85 0.01 1.43E-03 0.62 0.02 
1.21E-
03 
 
After taking the cluster centroids, the backward feature selection process was 
carried out in the presence and in the absence of novel descriptors of carrier 
mediated transport. The best set of physicochemical and structural descriptors 
resulted in 81% of molecules correctly classified (Table 21). The models were 
generated from 7 descriptors, all of which were MACCS structural keys. In the 
presence of novel descriptors, 27 descriptors are selected by backward feature 
selection. The combination of standard and PIDGIN predictions resulted in 85% 
correctly classified molecules (Table 21). There is therefore a statistically significant 
increase in model performance. By reducing the possibility of having a majority 
chemical series within the dataset, the novel descriptors are found to be important 
in predicting efflux ratio. This may be due to the original dataset containing 
molecules belonging to the same cluster, for which PIDGIN predictions are not 
important determinants of efflux ratio.  
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One may however argue that the improvement, although statistically significant, is 
not very meaningful in a practical sense. 
Table 22: Performance of Naïve Bayes in cluster centroid based efflux classification 
Descriptors Average  
Accuracy 
Accuracy 
(sd) 
P-value 
(Accuracy) 
Average 
Kappa 
Kappa 
(sd) 
P-value 
(Kappa) 
Standard 
0.76 0.01 - 0.44 0.03 - 
Standard 
and NMTS 0.76 0.01 0.81 0.44 0.02 0.49 
Standard 
and PIDGIN 0.77 0.01 0.19 0.47 0.02 0.01 
 
Table 22 shows the performance of the Naïve Bayes classifier in cluster centroid 
based efflux classification. A p-value of 0.01 indicates a significant improvement in 
Kappa when standard descriptors are combined with PIDGIN predictions. However, 
the improvement in Kappa does not appear to be large enough to have practical 
significance. As expected, the general performance of the classifier is reduced in 
comparison to when the original dataset is used. This is most likely a clearer picture 
of how the models are likely to perform on an external, diverse set of molecules.  
Table 23: Performance of Random Forest in cluster centroid based efflux 
classification 
Descriptors Average  
Accuracy 
Accuracy 
(sd) 
P-value 
(Accuracy) 
Average 
Kappa 
Kappa 
(sd) 
P-value 
(Kappa) 
Standard 
0.84 0.01 - 0.59 0.03 - 
Standard 
and NMTS 0.84 0.01 0.49 0.59 0.03 0.52 
Standard 
and PIDGIN 0.84 0.01 0.25 0.61 0.04 0.19 
 
Table 23 shows the performance of Random Forest classifier in centroid based efflux 
classification. The lack of p-values below the threshold 0.05 suggests that NMTS and 
PIDGIN predictions do not improve the overall predictive accuracy or agreement 
between actual and predicted efflux class. However, in comparison with the non-
clustered dataset, the reduction in predictive accuracy is most likely a signal that a 
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more representative set of molecules is used in model development. As such, one 
would expect this method to be more applicable to an external dataset. 
4.4.2 Conclusions  
 Efflux ratio is used in drug discovery and other biological fields to measure the effect 
of efflux transport on absorption. It is therefore important make predictions of efflux 
ratio in order to identify and avoid substrates of efflux transporters. The lack of 
studies aiming to develop QSAR models of efflux ratio means that direct 
comparisons of the findings of this study could not be made with findings from other 
studies. One reason is the lack of publicly available data from which models can be 
developed. Most in silico studies aim to predict the A-B caco-2 permeability of 
molecules and as such, data on B-A permeability from which efflux ratio can be 
calculated is scarce. The majority of studies into efflux transport aim to develop 
predictive models of specific transporters. The permeability glycoprotein (P-gp) is 
one of the most extensively investigated efflux transporters due to its ubiquitous 
impact on efflux transport. 
However, the classification QSAR models obtained in this study demonstrate that 
predictions of efflux ratio are at least as accurate as predictions of A-B and B-A 
permeability.  This presents a cheap and fast in-silico method that can be useful in 
predicting molecules that are likely to undergo efflux transport prior to synthesis.  
The novel descriptors did not appear to have a major impact on the performance of 
models in predicting efflux class. This raises questions over the usage of metabolite 
similarity as a metric for assessing the likelihood of molecules binding to membrane 
transporters.  Interestingly, a recent study by O’Hagan and Kell (O’Hagan & Kell, 
2015) who proposed metabolite similarity to quantify likelihood of molecules 
undergoing active transport, found no relationship between metabolite similarity 
and caco-2 permeability. Their explanation for this finding was that for some 
molecules, a few transporters may be relevant while for other molecules many 
transporters can contribute to their permeability. 
The use of predictions from the PIDGIN tool could be improved by higher coverage 
of membrane transporters in the tool. However, the performance of models 
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developed from cluster centroids gives a better picture of how models are likely to 
perform on chemically diverse external datasets.  
5. SUMMARY AND FUTURE WORK 
The aim of this section is to summarise the overall conclusions of this study, highlight 
interesting questions that arose and give an overview of avenues that can be 
pursued in future studies. 
5.1 Summary of conclusions 
To address the relative importance of carrier mediated transport and passive 
diffusion through QSAR models, general descriptors of carrier mediated transport 
were required.  Current state of the art QSAR models make use of physicochemical 
and structural descriptors that measure the likelihood of molecules undergoing 
passive diffusion. Many studies agree that current QSAR methods cannot fully 
account for the permeability of substrates of membrane transporters. 
The aim of this study was to develop predictive classification models of caco-2 
permeability that include novel descriptors of carrier-mediated transport and to 
evaluate the predictive performance of such models by means of statistical 
comparisons to models developed from standard physicochemical and structural 
property descriptors. In order to achieve these aims, three specific objectives were 
devised to guide this study.  
The first objective was to assess the applicability of metabolite-likeness as a 
potential descriptor of the likelihood of molecules undergoing carrier-mediated 
transport across the cell membrane. After the proposal that structural similarity to 
endogenous metabolites can be used to measure the likelihood of molecules to 
undergo carrier mediated transport, the concept of metabolite likeness was 
investigated. The findings of this study suggest that approved drugs are generally 
more similar to endogenous metabolites than molecules found in the general 
chemical space considered in drug discovery projects. The degree of similarity to 
metabolites was found to differ with different fingerprint encodings. Both approved 
drugs and commercial compounds showed highest similarity to metabolites when 
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structures were encoded by fragment dictionary based fingerprints compared with 
other fingerprint encodings. In all fingerprint encodings, approved drugs were 
consistently more similar to endogenous metabolites than commercially available 
compounds. This led to the conclusion that approved drugs are more likely to bind to 
membrane transporters which transport the drug’s structurally nearest metabolite. 
The nearest metabolite similarity was consequently used as a descriptor of carrier 
mediated transport in this study and thus the first objective was achieved.  
The second objective was to assess the applicability of a target prediction tool, 
PIDGIN, to predict potential substrates of caco-2 expressed membrane transporters 
within the dataset of caco-2 tested molecules provided by Evotec. In order to use 
PIDGIN for the purposes of this study, an investigation was conducted to assess the 
abundance of human transporter models within it. Because permeability data from 
caco-2 cells was used, one needs to know which transporters are sufficiently 
expressed in caco-2 cells and have models available in the tool. A caco-2 gene 
expression profile was obtained and a minimum expression threshold was sought. 
The finding of the study was that six membrane transporters that are sufficiently 
expressed in caco-2 cells had models available in the target prediction tool. This is a 
relatively small number of membrane transporters considering many studies suggest 
hundreds of membrane transporters are expressed in caco-2 cells. One of the 
difficulties faced in this investigation is the selection of a minimum expression 
threshold. Many studies concerning gene expression aim to assess differential 
expression between cells of interest. Because of this, one may consider the approach 
used in this study to be novel. The PIDGIN tool was consequently used as a source of 
novel descriptors. The minimum protein expression threshold was double the 
median expression value. The PIDGIN tool was consequently used to predict 
substrates of caco-2 expressed membrane transporters within the dataset of caco-2 
tested compounds. The binary output (0 meaning non-substrate and 1 meaning 
substrate of the relevant transporter) were consequently used as novel descriptors 
of carrier-mediated transport thus meeting the second objective of this study. 
The third and final objective of this study was to develop classification models of 
caco-2 permeability that incorporate the novel descriptors and to evaluate whether 
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the inclusion of novel descriptors offers statistically significant improvements in the 
predictive performance of such models. To achieve this objective, classification QSAR 
models were developed for predicting the caco-2 cell permeability and efflux ratio 
class of molecules. Three classification methods were used in this study: Logistic 
regression, Naïve Bayes and Random Forest classifiers. Models were developed to 
predict the caco-2 apparent permeability (Papp) in the apical to basolateral (A-B) and 
basolateral to apical (B-A) directions as well as efflux ratio class of molecules.  
The backward feature selection method was employed to select descriptors for the 
Logistic regression classifier. For predicting the A-B permeability, none of the novel 
descriptors of carrier mediated transport were selected as important. The Logistic 
regression classifier achieved a mean classification accuracy of 91% when generated 
with the selected set of physicochemical and structural property descriptors. For the 
Naïve Bayes and Random Forest classifiers, feature selection was carried out using 
low variance and correlation filters. There was no significant difference in 
performance between models generated from physicochemical and structural 
property descriptors alone and in combination with novel descriptors of carrier 
mediated transport. This suggests that the novel descriptors of carrier mediated 
transport do not improve the performance of models. To investigate the descriptors 
that contribute the most to predictive performance, descriptor randomization was 
carried out. The importance of certain substructures from the MACCS keys list 
suggests that the presence of some substructures in molecules could have an 
influence on their permeability. These substructures include hydroxyl and carbonyl 
groups which are relevant to protein binding. It is therefore likely that by including 
MACCS keys as descriptors, the likelihood of molecules undergoing carrier mediated 
transport is encoded. The third and final objective was therefore met since novel 
descriptors of carrier-mediated transport were used to develop models.  
The aim of this study, to incorporate novel descriptors of carrier-mediated transport 
in predictive modelling of caco-2 permeability, was achieved. Structural similarity to 
metabolites (NMTS) and PIDGIN target predictions were used as novel descriptors of 
carrier-mediated transport. However, the predictive performance of models 
developed with novel descriptors did not show statistically significant improvements 
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compared with models developed without the novel descriptors. These results 
suggest that better descriptors of carrier-mediated descriptors should be pursued if 
indeed carrier-mediated transport is as important as passive diffusion to the 
permeability of molecules across biological membranes. 
The permeability of molecules in the B-A direction may have an influence on its 
permeability. A review of the literature suggested that not many QSAR models of B-A 
permeability have been developed. For the dataset used, the majority of compounds 
were highly permeable in the B-A direction. It was therefore assumed that carrier-
mediated transport was more prevalent in the B-A direction for the set of molecules 
used in this study. The dataset was imbalanced for the B-A permeability and this had 
an impact on the performance of the models as shown by low values of Cohen’s 
Kappa. Only 50 molecules were impermeable in the B-A direction and more than 700 
were permeable. The dataset was balanced by clustering permeable compounds and 
taking the centroid of each cluster for model generation. The novel descriptors of 
carrier mediated transport (NMTS and PIDGIN target predictions) did not improve 
the performance of models. The most likely reason is that the information encoded 
by these novel descriptors is already contained within the physicochemical and 
structural descriptors used. Indeed the descriptor randomization process showed 
that certain substructures had an influence on the B-A permeability of molecules. 
Such substructures, as mentioned before, are relevant to protein binding and could 
in fact be capturing the likelihood of molecules undergoing carrier mediated 
transport. 
One reason why molecules may fail to show optimal permeability is because they are 
substrates of efflux transporters. The efflux ratio is used to measure the extent to 
which molecules undergo efflux transport. Because carrier mediated transport is of 
direct relevance to efflux ratio, one would expect novel descriptors of carrier 
mediated transport to be particularly important in predicting efflux ratio class. The 
Random Forest classifier shows the highest classification accuracy (90%) when 
generated from physicochemical and structural property descriptors. Addition of 
novel descriptors of carrier mediated transport failed to show significant 
improvements in the performance of classifiers on the original dataset. Clustering of 
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molecules in the efflux ratio dataset led to PIDGIN predictions being selected by the 
backward feature selection method. While models developed from the clustered 
dataset show statistically significant improvements with inclusion of PIDGIN 
predictions, the improvements were not considered practically significant.  
5.2 Future work 
In this study, the concept of metabolite likeness was applied to quantify the 
likelihood of molecules undergoing carrier mediated transport. However, the 
similarity to only the structurally closest endogenous metabolite was considered. In 
future, it may be beneficial to assess the number of endogenous metabolites to 
which a particular molecule is structurally very similar. For example, one may 
consider using the number of endogenous metabolites to which a molecule has a 
similarity score greater than a chosen threshold. This is likely to give a more 
comprehensive measure of metabolite similarity and a more robust quantification of 
likelihood of molecules to interact with membrane transporters.  
Another avenue for future work concerns the target prediction tool used in this 
study. The tool was developed based on active and inactive compounds for each of 
the protein targets available. For membrane transporters, active molecules can be 
substrates or inhibitors. In future work concerned with developing target prediction 
tools, active molecules should be further divided into substrates or inhibitors. It 
would also be beneficial, in future work, to develop robust methods of selecting a 
minimum expression threshold above which one can be confident that a gene of 
interest is sufficiently expressed. 
While cross validation was carried out for classification models developed in this 
study, in future, it is necessary to assess the performance of such models on an 
external dataset with compounds not used in the model development process. The 
performance of models on such datasets would provide a complete validation from 
which coherent conclusions can be made on the utility of models developed in this 
study. However, the lack of data on B-A permeability and thus efflux ratio could 
hinder the process of validating the models developed for predicting such 
properties.  
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7. Appendix 
 
Figure A. 1: KNIME workflow used to compare metabolite-likeness of approved 
drugs and commercially available compounds (Evosource compounds) 
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Table A. 1: Proteins with models available in the target prediction tool PIDGIN and 
expressed in caco-2 cells 
UniProt 
Accession Protein name 
Caco-2 RMA gene 
expression  
P49281 
solute carrier family 11 (proton-coupled divalent 
metal ion transporter), member 2 9.16 
P04114 apolipoprotein B 9.11 
Q15125 emopamil binding protein (sterol isomerase) 8.96 
P53985 
solute carrier family 16 (monocarboxylate 
transporter), member 1 7.62 
P06213 insulin receptor 7.28 
Q05513 protein kinase C, zeta 7.11 
P13569 
cystic fibrosis transmembrane conductance 
regulator (ATP-binding cassette sub-family C, 
member 7) 7.04 
P19634 
solute carrier family 9, subfamily A (NHE1, 
cation proton antiporter 1), member 1 7.01 
Q8WTV0 scavenger receptor class B, member 1 6.99 
P31645 
solute carrier family 6 (neurotransmitter 
transporter), member 4 6.81 
Q9UNQ0 
ATP-binding cassette, sub-family G (WHITE), 
member 2 (Junior blood group) 6.68 
P33527 
ATP-binding cassette, sub-family C (CFTR/MRP), 
member 1 6.64 
Q02156 protein kinase C, epsilon 6.64 
Q9HBY8 serum/glucocorticoid regulated kinase 2 6.62 
O00141 serum/glucocorticoid regulated kinase 1 6.60 
P31749 
v-akt murine thymoma viral oncogene homolog 
1 6.55 
P43003 
solute carrier family 1 (glial high affinity 
glutamate transporter), member 3 6.49 
P23975 
solute carrier family 6 (neurotransmitter 
transporter), member 2 6.48 
Q99808 
solute carrier family 29 (equilibrative nucleoside 
transporter), member 1 6.44 
P03372 estrogen receptor 1 6.16 
P31639 
solute carrier family 5 (sodium/glucose 
cotransporter), member 2 6.08 
P10415 B-cell CLL/lymphoma 2 6.07 
P43005 
solute carrier family 1 (neuronal/epithelial high 
affinity glutamate transporter, system Xag), 
member 1 6.03 
P08183 
ATP-binding cassette, sub-family B (MDR/TAP), 
member 1 5.95 
P42345 
mechanistic target of rapamycin 
(serine/threonine kinase) 5.87 
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Q16602 calcitonin receptor-like 5.85 
O60894 
receptor (G protein-coupled) activity modifying 
protein 1 5.84 
Q99523 sortilin 1 5.82 
Q01959 
solute carrier family 6 (neurotransmitter 
transporter), member 3 5.80 
Q12908 
solute carrier family 10 (sodium/bile acid 
cotransporter), member 2 5.66 
Q16572 
solute carrier family 18 (vesicular acetylcholine 
transporter), member 3 5.57 
Q09428 
ATP-binding cassette, sub-family C (CFTR/MRP), 
member 8 5.48 
Q9Y345 
solute carrier family 6 (neurotransmitter 
transporter), member 5 5.35 
P13866 
solute carrier family 5 (sodium/glucose 
cotransporter), member 1 5.27 
P22748 carbonic anhydrase IV 5.23 
O60706 
ATP-binding cassette, sub-family C (CFTR/MRP), 
member 9 5.08 
Q9NY91 
solute carrier family 5 (glucose activated ion 
channel), member 4 5.07 
P48067 
solute carrier family 6 (neurotransmitter 
transporter, glycine), member 9 5.06 
Q13255 glutamate receptor, metabotropic 1 5.02 
P31644 
gamma-aminobutyric acid (GABA) A receptor, 
alpha 5 4.96 
P43004 
solute carrier family 1 (glial high affinity 
glutamate transporter), member 2 4.95 
P05771 protein kinase C, beta 4.88 
P00918 carbonic anhydrase II 4.84 
P31751 
v-akt murine thymoma viral oncogene homolog 
2 4.81 
P54646 
protein kinase, AMP-activated, alpha 2 catalytic 
subunit 4.74 
P08913 adrenoceptor alpha 2A 4.32 
Q9Y210 
transient receptor potential cation channel, 
subfamily C, member 6 4.30 
Q13131 
protein kinase, AMP-activated, alpha 1 catalytic 
subunit 4.14 
P30531 
solute carrier family 6 (neurotransmitter 
transporter), member 1 3.71 
RMA: Robust Multi-array Average gene expression values 
 
 
112 
 
 
Figure A. 2: KNIME workflow implementing the backward feature selection for the 
Logistic regression classifier 
 
Table A. 2: Descriptors selected by backward feature selection for A-B classification 
with Logistic regression 
Molecular Descriptor 
Aliphatic ring count 
Acceptor count 
Strongest BASIC pKa 2 
logD at pH=5.0 
logD at pH=7.4 
Polar surface area 
 #atoms in 4 ring 
 #C = bonded to C and 3 heavy atoms 
 #atoms in 3 ring 
 #C bonded to at least 3 N atoms 
 #QH 3 bonds from another QH 
 #non-ring bonds that connect rings 
 #S in double/charge separated bonds 
 #N non-ring bonded to a ring 
 #C in C=C bonded to >= 3 heavy atoms 
 #N separated by 4 bonds 
 #heteroatoms in 5 ring 
 #XQ>3 bonded to at least 1 halogen 
 #N in double bonds 
 #het-het bonds 
 #CH2s separated by 4 bonds 
 #halogens 
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 Total # ring HETEROCYCLE atoms 
 #OH groups 
(key(160)-1 if key(160)>1; else 0) 
Key160 = #CH3 groups 
 #O in C=O 
 #XN where coord. # of X>=3  
 #N in C-N single bonds 
 Key(164)-1 if key(164)>1; else 0 
key164 = #Oxygens 
 #N 
 #ring atoms 
 
Table A. 3: Descriptors selected by backward feature selection for B-A classification 
with Logistic regression 
Molecular Descriptor 
Fused aliphatic ring count 
Strongest ACIDIC pKa 2 
Strongest BASIC pKa 2 
logD at pH=6.5 
#C bonded to at least 3 N atoms 
#S atoms bonded to N 
#N in C#N 
#O in rings 
#N non-ring bonded to a ring 
#CH2 or CH3 separated by non-C 
#halogens bonded to any ring 
#methylated heteroatoms 
#atoms in 5-rings 
#N attached to CH2 
#O separated by 1 C 
#CH2s separated by 4 bonds 
#CH2s separated by 3 bonds 
(# het atoms with H) 
#N non-ring bonded to a ring 
Bit: is there more than 1 O= 
Total # ring HETEROCYCLE atoms 
#O in C=O 
#non-ring CH2 
#O in C-O single bonds 
#N in C-N single bonds 
#N 
#ring atoms 
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Table A. 4: Descriptors selected by the backward feature selection for efflux ratio 
classification 
Descriptors 
#N 
#halogens 
#CH2s separated by 3 bonds 
#heteroatoms in 5ring 
#non-C with coordination number >=3 
#O in C=O 
#N attached to CH2 
#CH2s separated by 4 bonds 
#N bonded to >= 3 C 
#methylated heteroatoms 
Bit: is there more than 1 O= 
#S in double/charge separated bonds 
#CH3 groups 
#N attached to CH2 
#atoms in 5 membered rings 
#atoms separated by (!:):(!:) 
Strongest ACIDIC pKa 1 
#OH groups 
#C in C=C 
#heteroatoms in 5 ring 
 
